SCIO DIAMOND TECHNOLOGY CORP, 10-K filed on 8/15/2014
Annual Report
Document and Entity Information (USD $)
12 Months Ended
Mar. 31, 2014
Aug. 8, 2014
Sep. 30, 2013
Document and Entity Information
 
 
 
Entity Registrant Name
Scio Diamond Technology Corp 
 
 
Entity Central Index Key
0001488934 
 
 
Document Type
10-K 
 
 
Document Period End Date
Mar. 31, 2014 
 
 
Amendment Flag
false 
 
 
Current Fiscal Year End Date
--03-31 
 
 
Entity Well-known Seasoned Issuer
No 
 
 
Entity Voluntary Filers
No 
 
 
Entity Current Reporting Status
Yes 
 
 
Entity Filer Category
Smaller Reporting Company 
 
 
Entity Public Float
 
 
$ 15,298,557 
Entity Common Stock, Shares Outstanding
 
50,619,312 
 
Document Fiscal Year Focus
2014 
 
 
Document Fiscal Period Focus
FY 
 
 
BALANCE SHEETS (USD $)
Mar. 31, 2014
Mar. 31, 2013
Current Assets:
 
 
Cash and cash equivalents
$ 47,987 
$ 223,257 
Accounts receivable, net
42,085 
69,042 
Other receivables
89,192 
 
Inventory
152,817 
538,948 
Prepaid expenses
79,078 
34,455 
Prepaid rent
23,050 
23,050 
Total current assets
434,209 
888,752 
Property, plant and equipment
 
 
Facility
899,499 
883,246 
Manufacturing equipment
3,171,656 
3,813,865 
Other equipment
71,059 
69,311 
Total property, plant and equipment
4,142,214 
4,766,442 
Less accumulated depreciation
(1,029,212)
(493,533)
Net property, plant and equipment
3,113,002 
4,272,909 
Intangible assets, net
9,240,640 
10,015,651 
Prepaid rent, noncurrent
42,288 
65,338 
Other assets
20,000 
13,800 
TOTAL ASSETS
12,850,139 
15,256,450 
Current Liabilities:
 
 
Notes payable
1,412,060 
 
Accounts payable
671,782 
285,651 
Customer deposits
179,610 
 
Accrued expenses
573,126 
730,698 
Total current liabilities
2,836,578 
1,016,349 
Other liabilities
84,144 
50,195 
TOTAL LIABILITIES
2,920,722 
1,066,544 
Common stock, $0.001 par value, 75,000,000 shares authorized; 50,739,312 and 47,736,812 shares issued and outstanding at March 31, 2014 and 2013, respectively
50,739 
47,737 
Additional paid-in capital
24,476,940 
23,789,478 
Accumulated deficit
(14,597,262)
(9,646,309)
Treasury stock, 1,000,000 at March 31, 2014 and 2013, respectively
(1,000)
(1,000)
Total stockholders' equity
9,929,417 
14,189,906 
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
$ 12,850,139 
$ 15,256,450 
BALANCE SHEETS (Parenthetical) (USD $)
Mar. 31, 2014
Mar. 31, 2013
BALANCE SHEETS
 
 
Common stock, par value (in dollars per share)
$ 0.001 
$ 0.001 
Common stock, shares authorized
75,000,000 
75,000,000 
Common stock, shares issued
50,739,312 
47,736,812 
Common stock, shares outstanding
50,739,312 
47,736,812 
Treasury stock, shares
1,000,000 
1,000,000 
STATEMENTS OF OPERATIONS (USD $)
12 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Revenue
 
 
Product revenue, net
$ 793,341 
$ 881,748 
Licensing revenue
625,000 
 
Revenues, net
1,418,341 
881,748 
Cost of goods sold
 
 
Cost of goods sold
2,321,534 
1,349,109 
Gross margin (deficit)
(903,193)
(467,361)
General, administrative, and pre-operating expenses
 
 
Professional and consulting fees
1,272,212 
2,635,069 
Salaries and benefits
723,805 
3,086,505 
Rent, equipment lease and facilities expense
150,502 
300,261 
Marketing costs
49,216 
48,403 
Depreciation and amortization
799,928 
393,010 
Corporate general and administrative
379,552 
364,265 
Loss on disposal of fixed assets
129,308 
 
Loss on impairment of fixed assets
381,798 
 
Total general and administrative expenses
3,886,321 
6,827,513 
Loss from operations
(4,789,514)
(7,294,874)
Other income (expense)
 
 
Interest expense
(161,439)
 
Forgiveness of interest expense
 
12,522 
Net loss
$ (4,950,953)
$ (7,282,352)
Basic:
 
 
Weighted average number of shares outstanding (in shares)
49,548,045 
37,971,035 
Loss per share (in dollars per share)
$ (0.10)
$ (0.19)
Fully diluted:
 
 
Weighted average number of shares outstanding (in shares)
49,548,045 
37,971.035 
Loss per share (in dollars per share)
$ (0.10)
$ (0.19)
STATEMENTS OF CASH FLOW (USD $)
12 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Cash flows from operating activities:
 
 
Net loss
$ (4,950,953)
$ (7,282,352)
Adjustments to reconcile net loss to net cash used in operating activities:
 
 
Depreciation and amortization
1,574,418 
859,983 
Loss on disposal of equipment
129,308 
 
Loss on impairment of fixed assets
381,798 
 
Expense for warrants, stock and inventory issued in exchange for services
421,496 
158,560 
Forgiveness of interest expense
 
(12,522)
Expense for stock allocated for indemnification of directors
 
830,000 
Employee stock based compensation
193,150 
1,996,426 
Inventory write down
100,557 
 
Changes in assets and liabilities:
 
 
Decrease/(increase) in accounts receivable
26,957 
(69,042)
Increase in other receivables
(89,192)
 
Decrease/(increase) in prepaid expenses, rent and other assets
44,260 
(26,411)
Decrease/(increase) in inventory
258,127 
(267,446)
Increase in accounts payable
386,131 
87,587 
Increase in customer deposits
179,610 
 
Increase/(decrease) in accrued expenses
(54,436)
342,783 
Increase in other liabilities
33,949 
50,195 
Net cash used in operating activities
(1,364,820)
(3,332,239)
Cash flows from investing activities:
 
 
Purchase of property, plant and equipment
(71,889)
(1,114,420)
Net cash used in investing activities
(71,889)
(1,114,420)
Cash flows from financing activities:
 
 
Proceeds from sale of common stock and warrant exercise - net of fees
129 
4,086,400 
Proceeds from notes payable
1,412,060 
 
Finance charges paid on note payable
(150,750)
 
Payments on notes payable
 
(225,000)
Net cash provided by financing activities
1,261,439 
3,861,400 
Change in cash and cash equivalents
(175,270)
(585,259)
Cash and cash equivalents, beginning of period
223,257 
808,516 
Cash and cash equivalents, end of period
47,987 
223,257 
Cash paid during the year for:
 
 
Interest
18,874 
 
Non-cash investing and financing activities:
 
 
Purchase of assets funded by note payable
 
100,000 
Warrants issued for real property lease
 
39,000 
Warrants issued for consulting services
13,985 
113,760 
Purchase of assets funded through ADGC subscription rights
 
770,000 
Common stock allocated for indemnification of directors
 
830,000 
Manufacturing equipment transferred to assets held for sale
$ 20,000 
 
STATEMENTS OF SHAREHOLDERS' EQUITY (USD $)
Total
Common Stock
Additional Paid in Capital
Treasury Stock
Accumulated Deficit
Balance at Mar. 31, 2012
$ 13,599,672 
$ 26,013 
$ 15,937,616 
 
$ (2,363,957)
Balance (in shares) at Mar. 31, 2012
 
26,013,070 
 
 
 
Increase (Decrease) in Stockholders' Equity
 
 
 
 
 
Common stock issued for cash, net of fees, at $0.80 per share
3,873,177 
4,891 
3,868,286 
 
 
Common stock issued for cash, net of fees, at $0.80 per share (in shares)
 
4,891,250 
 
 
 
Common Stock issued for cash, net of fees, at $0.01 per share
199,595 
16,768 
182,827 
 
 
Common Stock issued for cash, net of fees, at $0.01 per share (in shares)
 
16,766,773 
 
 
 
Common stock issued in exchange for consulting services
37,000 
46 
36,954 
 
 
Common stock issued in exchange for consulting services (in shares)
46,250 
46,250 
 
 
 
Warrants exercised for common stock, net of fees, at $0.70 per share
13,628 
19 
13,609 
 
 
Warrants exercised for common stock, net of fees, at $0.70 per share (in shares)
19,469 
19,469 
 
 
 
Treasury stock acquired
 
 
1,000 
(1,000)
 
Treasury stock acquired (in shares)
 
 
 
(1,000,000)
 
Subscription rights issued for purchase of assets
770,000 
 
770,000 
 
 
Warrants issued for real property lease
39,000 
 
39,000 
 
 
Common stock issued for indemnification of legal settlement
830,000 
 
830,000 
 
 
Employee stock based compensation
1,996,426 
 
1,996,426 
 
 
Warrants issued in exchange for consulting services
113,760 
 
113,760 
 
 
Net loss for the period
(7,282,352)
 
 
 
(7,282,352)
Balance at Mar. 31, 2013
14,189,906 
47,737 
23,789,478 
(1,000)
(9,646,309)
Balance (in shares) at Mar. 31, 2013
47,736,812 
47,736,812 
 
(1,000,000)
 
Increase (Decrease) in Stockholders' Equity
 
 
 
 
 
Common stock issued in exchange for consulting services
319,200 
1,002 
318,198 
 
 
Common stock issued in exchange for consulting services (in shares)
527,500 
1,002,500 
 
 
 
Common stock issued in exchange for past legal services
164,000 
1,000 
163,000 
 
 
Common stock issued in exchange for past legal services (in shares)
1,000,000 
1,000,000 
 
 
 
Administrative fee received for previous stock issuance
129 
 
129 
 
 
Common stock issued for indemnification of legal settlement
 
1,000 
(1,000)
 
 
Common stock issued for indemnification of legal settlement (in shares)
1,000,000 
1,000,000 
 
 
 
Employee stock based compensation
193,150 
 
193,150 
 
 
Warrants issued in exchange for consulting services
13,985 
 
13,985 
 
 
Net loss for the period
(4,950,953)
 
 
 
(4,950,953)
Balance at Mar. 31, 2014
$ 9,929,417 
$ 50,739 
$ 24,476,940 
$ (1,000)
$ (14,597,262)
Balance (in shares) at Mar. 31, 2014
50,739,312 
50,739,312 
 
(1,000,000)
 
STATEMENTS OF SHAREHOLDERS' EQUITY (Parenthetical)
12 Months Ended
Mar. 31, 2013
STATEMENTS OF SHAREHOLDERS' EQUITY
 
Issue price per unit (in dollars per share)
$ 0.80 
Additional common stock issued for cash, issue price (in dollars per share)
$ 0.01 
Common stock issued in exchange for services, issue price (in dollars per share)
$ 0.80 
Warrants exercised for common stock, issue price (in dollars per share)
$ 0.70 
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

 

NOTE 1 — ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Organization and Business

 

Scio Diamond Technology Corporation (referred to herein as the “Company”, “we”, “us” or “our”) was incorporated under the laws of the State of Nevada as Krossbow Holding Corp. on September 17, 2009. The Company’s focus is on man-made diamond technology development and commercialization.

 

Going Concern

 

The Company has generated very little revenue to date and consequently its operations are subject to all risks inherent in the establishment and commercial launch of a new business enterprise.

 

These factors raise substantial doubt about the Company’s ability to continue as a going concern. Management has responded to these circumstances by taking the following actions:

 

·         On-going solicitation of investment in the Company in the form of private placements of common shares, secured and unsecured debt to accredited investors;

·         Focused efforts on new business development opportunities to generate revenues and diversify our customer base;

·         Enhanced efforts on optimizing production for existing manufacturing capabilities; and

·         Continued to explore strategic joint ventures, technology licensing agreements and dedicated contract manufacturing to expand company revenue and cash flow, including our recently agreed to joint venture in China.

 

In the opinion of management, these actions will be sufficient to provide the Company with the liquidity it needs to meet its obligations and continue as a going concern. There can be no assurance, however, that the Company will successfully implement these plans. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

Accounting Basis

 

The financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and the disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates, including those related to revenue recognition, provision for doubtful accounts, sales returns, provision for inventory obsolescence, fair value of acquired intangible assets, useful lives of intangible assets and property and equipment, employee stock options, and contingencies and litigation, among others. The Company generally bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual amounts recorded could differ materially from those estimates

 

In accordance with Accounting Standards Codification (“ASC”) 323, Investments—Equity Method and Joint Ventures, the Company uses the equity method of accounting for investments in corporate joint ventures for which the Company has the ability to exercise significant influence but does not control and is not the primary beneficiary. Significant influence typically exists if the Company has a 20% to 50% ownership interest in the venture unless predominant evidence to the contrary exists. Under this method of accounting, the Company records its proportionate share of the net earnings or losses of equity method investees and a corresponding increase or decrease to the investment balances. Cash payments to equity method investees such as additional investments, loans and advances and expenses incurred on behalf of investees, as well as payments from equity method investees such as dividends, distributions and repayments of loans and advances are recorded as adjustments to investment balances. When the Company’s carrying value in an equity method investee is reduced to zero, no further losses are recorded in the Company’s financial statements unless the Company guaranteed obligations of the equity method investee or has committed additional funding.  When the equity method investee subsequently reports income, the Company will not record its share of such income until it equals the amount of its share of losses not previously recognized.  The Company evaluates its equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts of such investments may not be recoverable.

 

Fair Value of Financial Instruments

 

The carrying value of cash and cash equivalents,  accounts payable and notes payable approximate their fair value due to the short-term nature of these instruments.

 

Cash and Cash Equivalents

 

For purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with an original maturity of three months or less when purchased to be cash equivalents.  At March 31, 2014 and 2013, the Company held no cash equivalents.

 

Basic and Diluted Net Loss per Share

 

Net loss per share is presented under two formats: basic net loss per common share, which is computed using the weighted average number of common shares outstanding during the period, and diluted net loss per common share, which is computed using the weighted average number of common shares outstanding, and the weighted average dilutive potential common shares outstanding, computed using the treasury stock method. Currently, for all periods presented, diluted net loss per share is the same as basic net loss per share as the inclusion of weighted average shares of common stock issuable upon the exercise of options and warrants would be anti-dilutive.

 

The following table summarizes the number of securities outstanding at each of the periods presented, which were not included in the calculation of diluted net loss per share as their inclusion would be anti-dilutive:

 

 

 

March 31,

 

 

 

2014

 

2013

 

Common stock options and warrants

 

9,909,295

 

9,609,295

 

 

Allowance for Doubtful Accounts

 

An allowance for uncollectible accounts receivable is maintained for estimated losses from customers’ failure to make payment on accounts receivable due to the Company. Management determines the estimate of the allowance for uncollectible accounts receivable by considering a number of factors, including: (1) historical experience, (2) aging of accounts receivable and (3) specific information obtained by the Company on the financial condition and the current credit worthiness of its customers. The Company also maintains a provision for estimated returns and allowances based upon historical experience.  The Company has determined that an allowance was not necessary at March 31, 2014 or 2013.

 

Other Receivables

 

As of March 31, 2014, the Company considered a pending insurance settlement over the actions of a Company supplier of $89,192 as an other receivable.  This settlement was agreed to but not paid at March 31, 2014.

 

Inventories

 

Inventories are stated at the lower of average cost or market. The carrying value of inventory is reviewed and adjusted based upon slow moving and obsolete items. Inventory costs include material, labor, and manufacturing overhead and are determined by the “first-in, first-out” (FIFO) method.  The components of inventories are as follows:

 

 

 

March 31,
2014

 

March 31,
2013

 

Raw materials and supplies

 

$

35,543

 

$

64,255

 

Work in process

 

25,611

 

 

Finished goods

 

91,663

 

474,693

 

 

 

$

152,817

 

$

538,948

 

 

During the fiscal year ended March 31, 2014, we recorded a lower cost of market write down for inventory of $100,557 due to expected selling prices being lower than cost.  The estimation of the total write-down involves management judgments and assumptions, including assumptions regarding future selling price forecasts, the estimated costs to complete and disposal costs.

 

Property, Plant and Equipment

 

Depreciation of property, plant and equipment is on a straight line basis beginning at the time it is placed in service, based on the following estimated useful lives:

 

 

 

Years

 

Machinery and equipment

 

3–15

 

Furniture and fixtures

 

3–10

 

Engineering equipment

 

5–12

 

 

Leasehold improvements are depreciated over the lesser of the remaining term of the lease or the life of the asset (generally three to seven years).

 

Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized. Expenditures for maintenance and repairs are charged to expense as incurred. Manufacturing equipment was placed into service beginning July 1, 2012.  The Company incurred total depreciation expense of $700,690 and $490,136 for the years ended March 31, 2014 and 2013, respectively.

 

During the fiscal year ended March 31, 2014, the Company closed its operations in Hudson, Massachusetts.  With this closing the Company recognized a loss of $129,308 for the disposal of certain fixed assets at the location.  Concurrent with the closing of the Hudson facility, the Company re-evaluated the useful life of certain fixed assets acquired from Apollo Diamond in 2012 and decided that an impairment reserve related to these assets of $381,798 was appropriate.

 

Intangible Assets

 

Intangible assets, such as acquired in-process research and development costs, are considered to have an indefinite useful life until such time as they are put into service at which time they will be amortized on a straight-line basis over the shorter of their economic or legal useful life. Management evaluates indefinite life intangible assets for impairment on an annual basis and on an interim basis if events or changes in circumstances between annual impairment tests indicate that the asset might be impaired. The ongoing evaluation for impairment of its indefinite life intangible assets requires significant management estimates and judgment. Management reviews definite life intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. There are no impairment charges during the years ended March 31, 2014 or 2013.

 

Income Taxes

 

Income taxes are accounted for under the asset and liability method. Deferred income taxes reflect the tax consequences on future years of differences between the tax bases of assets and liabilities and their financial reporting amounts. Valuation allowances are provided against deferred tax assets when it is more likely than not that an asset will not be realized in accordance with Accounting Standards Codification (“ASC”) 740, Accounting for Income Taxes.

 

Management has evaluated the potential impact in accounting for uncertainties in income taxes and has determined that it has no significant uncertain income tax positions as of March 31, 2014 or 2013.  Income tax returns subject to review by taxing authorities include March 31, 2010 through March 31, 2014.

 

Stock-based Compensation

 

Stock-based compensation for the value of stock options is estimated on the date of the grant using the Black-Scholes option-pricing model. The Black-Scholes model takes into account implied volatility in the price of the Company’s stock, the risk-free interest rate, the estimated life of the equity-based award, the closing market price of the Company’s stock on the grant date and the exercise price. The estimates utilized in the Black-Scholes calculation involve inherent uncertainties and the application of management judgment.

 

Concentration of Credit Risk

 

During the year ended March 31, 2014 the Company had 27 different customers.  One customer accounted for 58% of our total product revenue.  For the year ended March 31, 2013, one customer accounted for 84% of total revenues for the Company and purchased substantially all of the Company’s production output. The second customer purchased a substantial portion of the Company’s by-product inventory and accounted for 11% of total revenues for the Company.

 

Fair Value Measurement

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy prescribed by the accounting literature contains three levels as follows:

 

Level 1— Quoted prices in active markets for identical assets or liabilities.

 

Level 2— Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3— Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation.

 

In addition, GAAP requires the Company to disclose the fair value for financial assets on both a recurring and non-recurring basis. During June 2012, the Company issued to certain current and former stockholders of Apollo Diamond Gemstone Corporation (“ADGC”) that are accredited investors subscription rights valued at $770,000 for the purchase of ADGC assets disclosed in Note 2 measured at fair value on a nonrecurring basis. The fair value of the ADGC subscription rights was determined using the Black-Scholes model whose assumptions were considered by management to be a Level 3 input.

 

Revenue Recognition

 

We recognize product revenue when persuasive evidence of an arrangement exists, delivery of products has occurred, the sales price is fixed or determinable, and collectability is reasonably assured. For our Company, this generally means that we recognize revenue when we or our fabrication vendor has shipped finished product to the customer. Our sales terms do not allow for a right of return except for matters related to any manufacturing defects on our part.  The Company recognizes licensing and development revenues in accordance with the contractual terms of the agreements.

 

Recent Accounting Pronouncements

 

In July 2012, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2012-02, Testing Indefinite-Lived Intangible Assets for Impairment (the revised standard). Under the amendments in this updates, a company has the option first to assess qualitative factors to determine whether the existence of events and circumstances indicates that the it is more likely than not that the indefinite-lived intangible assert is impaired as a basis for determining whether it is necessary to perform the qualitative impairment test in accordance with Topic 350.  The more likely than not threshold is defined as having a likely-hood of more than fifty percent.  If after assessing the qualitative factors, a company determines it does not meet the more likely than not threshold, a company is required to perform the quantitative impairment test by calculating the fair value of an indefinite-lived intangible asset and comparing the fair value with the carrying amount of the asset.  The Amendments in this update are effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. The Company adopted this new standard in the fiscal year ended March 31, 2013 and the adoption did not have a significant impact on its financial statements.

 

In July 2013, the FASB issued ASC 2013-11, “Income Taxes — Presentation of an Unrecognized Tax benefit When a Net Operation Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists”  (“ASU 2013-11”) which is part of Accounting Standards Codification (“ASC”) 740: Income Taxes.  The new guidance requires and entity to present an unrecognized tax benefit and an NOL carryforward, a similar tax loss or a tax credit carryforward on a net basis as part of a deferred tax asset, unless the unrecognized tax benefit is not available to reduce the deferred tax asset component or would not be utilized for that purpose, then a liability would be recognized.  ASU 2013-11 is effective for annual and interim periods for fiscal years beginning after December 15, 2013.  The Company is currently evaluating the impact of the April 1, 2014 adoption of this guidance on its consolidated financial statements.

 

In May 2014, the FASB issued ASU 2014-9 “Revenue from Contracts with Customers (Topic 606).” This guidance requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This guidance is effective for annual reporting periods beginning after December 15, 2016 and early adoption is not permitted. The Company will adopt this standard in fiscal year 2018. The Company has not yet determined the effect, if any, that the adoption of this standard will have on the Company’s financial position or results of operations.

 

There are currently no other accounting standards that have been issued but not yet adopted by the Company that will have a significant impact on the Company’s financial position, results of operations or cash flows upon adoption.

 

ASSET PURCHASES
ASSET PURCHASES

 

 

NOTE 2 — ASSET PURCHASES

 

On June 5, 2012, the Company acquired certain of the assets of ADGC (the “ADGC Asset Purchase”), consisting primarily of lab-created diamond gemstone-related know-how, inventory, and various intellectual property, in exchange for $100,000 in cash and the right for certain current and former stockholders of ADGC qualifying as accredited investors to acquire up to approximately 1 million shares of common stock of the Company for $0.01 per share (the “ADGC Offering”) with the intent that the ADI Offering be conducted substantially concurrently with the ADGC Offering (collectively, the “ADI/ADGC Stockholder Offering”). The Company paid the $100,000 cash portion of the ADGC Asset Purchase during the month of December 2012. The ADI/ADGC Stockholder Offering began in June and was completed in March 2013. At the date of the transaction, the Company estimated the fair value of such subscription rights to be $0.79 per right and the aggregate fair value of such subscription rights was $790,000.  This amount was credited to additional paid-in capital. The fair value of such rights to acquire shares of common stock of the Company was determined using the Black-Scholes model. Subsequent to the date of the transaction, the Company obtained a third-party valuation to support the fair value of the assets acquired. This valuation determined a slightly lower value of $770,000 for the subscription rights and adjusted the purchase price allocation between inventory and in-process research and development.  Adjustments were made in the March 31, 2013 financial statements to reflect this modification of final purchase price and asset allocation.  The final amounts allocated to the ADGC assets acquired are based upon the results of that valuation appraisal and the following table reflects our final purchase price allocation of the assets:

 

Inventory

 

$

269,000

 

In-process research and development

 

601,000

 

Total

 

$

870,000

 

 

The ADI/ADGC Stockholder Offering was completed in March 2013 and resulted in the issuance of an aggregate of 16,766,773 shares of the Company’s common stock.

 

INTANGIBLE ASSETS
INTANGIBLE ASSETS

 

NOTE 3 — INTANGIBLE ASSETS

 

During the year ended March 31, 2014, the Company evaluated its patent portfolio and allocated $601,000 of the previously acquired in-process research and development from the ADGC Asset Purchase to specific patents related to the gemstone market that are being used by the Company for its commercial operations. These patents were considered placed in service by the Company during the quarter ended June 30, 2013.  During the year ended March 31, 2013, the Company evaluated its patent portfolio and allocated $7,534,063 of the previously acquired in-process research and development to specific patents that are being used by the Company for its manufacturing operations. The assigned values of all patents considered in service by the Company are being amortized on a straight-line basis over the remaining effective lives of the patents.

 

Intangible assets, such as acquired in-process research and development costs, are considered to have an indefinite useful life until such time as they are put into service at which time they will be amortized on a straight-line basis over the shorter of their economic or legal useful life.

 

Intangible assets consist of the following:

 

 

 

 

 

March 31,

 

March 31,

 

 

 

Life

 

2014

 

2013

 

Patents, gross

 

6.75 – 19.46

 

$

8,135,063

 

$

7,543,063

 

In-process research and development

 

Indefinite

 

2,250,435

 

2,851,435

 

 

 

 

 

10,385,498

 

10,385,498

 

Accumulated amortization

 

 

 

(1,144,858

)

(369,847

)

Net intangible assets

 

 

 

$

9,240,640

 

$

10,015,651

 

 

Total amortization expense during the years ended March 31, 2014 and 2013 was $775,011 and $369,847, respectively.

 

Total annual amortization expense of finite lived intangible assets is estimated to be as follows:

 

Fiscal Year Ending

 

 

 

March 31, 2015

 

$

775,011

 

March 31, 2016

 

775,011

 

March 31, 2017

 

775,011

 

March 31, 2018

 

775,011

 

March 31, 2019

 

775,011

 

Thereafter

 

$

3,115,150

 

 

NOTES PAYABLE
NOTES PAYABLE

 

 

NOTE 4 — NOTES PAYABLE

 

On June 21, 2013, the Company entered into a loan agreement (the “Original Loan Agreement”) with Platinum Capital Partners, LP (“Platinum”) providing for a $1 million secured revolving line of credit that the Company may draw on to fund working capital and other corporate purposes.  Borrowings under the loan agreement accrue interest at the rate of 18% per annum, payable monthly on or before the last calendar day of each month.  The Original Loan Agreement also provides for payment of an accommodation fee of up to 10% of the commitment amount as provided in the loan agreement, and payment of a monthly collateral monitoring fee of $2,000 per month for the first six months and $1,000 per month for the last six months of the term of the loan agreement.  The Original Loan Agreement contains a number of restrictions on the Company’s business, including restrictions on its ability to merge, sell assets, create or incur liens on assets, make distributions to its shareholders and sell, purchase or lease real or personal property or other assets or equipment.  The Original Loan Agreement also contains affirmative covenants and events of default.  The Company may prepay borrowings without premium or penalty upon notice to Platinum as provided in the Original Loan Agreement.  Under a security agreement entered into in connection with the loan agreement, the Company granted Platinum a first priority security interest in the Company’s inventory, equipment, accounts and other rights to payments and intangibles as security for the loan.

 

On October 11, 2013, the Company entered into a First Amendment to Loan Agreement (the “First Amendment”), dated October 11, 2013, with Platinum, which amends the Original Loan Agreement (as amended by the First Amendment, the “Amended Loan Agreement”) to provide for an additional $500,000 of borrowing capacity (the “Additional Loan” and, together with the original Loan, the “Loan”) under the existing $1 million secured revolving line of credit established under the Original Loan Agreement.  The Company may draw on the line to fund working capital.  On October 11, 2013, $280,750 was drawn on the Additional Loan, $30,750 of which was retained by Platinum to cover applicable fees.

 

Borrowings accrue interest at the rate of 18% per annum, payable monthly on or before the last calendar day of each month. An interest reserve of $133,500 has been set aside from the proceeds of the New Note to make required payments of interest, provided that interest billed to the Company will first be deducted from a $90,000 reserve established under the Original Note for payments of interest on the Original Note, until that reserve has been exhausted. The Amended Loan Agreement also provides for payment of an accommodation fee of $25,000 and a closing fee of $3,250, the amounts of which were retained by Platinum out of amounts drawn on the Additional Loan on October 11, 2013.  The Company’s obligations under the Amended Loan Agreement are not guaranteed by any other party.  The Company may prepay borrowings without premium or penalty upon notice to Platinum as provided in the Amended Loan Agreement.  The Loan is secured by a security agreement, under which the Company grants Platinum first priority security interest in the Company’s inventory, equipment, accounts and other rights to payments and intangibles as security for the Loan.  The New Note provides for monthly interest payments commencing November 2013 and for repayment of all amounts drawn, together with accrued interest, on June 20, 2014.

 

The Company has utilized funds drawn on the Original Loan and the Additional Loan to fund its ongoing operations.  The Company has capitalized financing costs related to the Platinum loans of $150,750 that are being amortized over the life of the loans.  The Company recognized $90,917 in amortization expense related to capitalized financing costs during the year ended March 31, 2014.  At March 31, 2014, the total due Platinum including all accrued fees was $1,412,060 and the Company was compliant with all financial debt convents.  At March 31, 2014 the total due Platinum consisted of $1,160,000 in principal borrowings, $121,310 in interest paid with loan advances and $130,750 in commitment and other loan fees.

 

The Platinum notes matured on June 20, 2014 and the Company went into default status. In default status, Platinum could foreclose on the loan and has the right to take possession of the collateral including the Company’s fixed assets and intellectual property.  In addition, in default status, Platinum has the right to increase the interest rate on the note by 3% upon 30 day notice to the Company.  To date, Platinum has not taken any action related to this default, including adjusting the interest rate, as the Company continues to pursue additional financing alternatives.

 

CAPITAL STOCK
CAPITAL STOCK

 

 

NOTE 5 — CAPITAL STOCK

 

The authorized capital of the Company is 75,000,000 common shares with a par value of $ 0.001 per share.

 

During the fiscal year ended March 31, 2013 the Company had the following issuances of capital stock:

 

·         The Company issued 1 million subscription rights with an exercise price of $0.01 per share to certain current and former stockholders of ADGC as part of the ADGC asset purchases discussed in Note 2.

·         The Company issued 4,891,250 units, each consisting of one share of common stock and one warrant for the purchase of a share of common stock at a strike price of $1.60 at a unit price of $0.80 for total net cash proceeds of $3,913,000.

·         The Company issued 16,766,773 shares of common stock under the ADI and ADGC subscription rights.

·         The Company issued 46,250 shares of common stock in lieu of cash payments to certain vendors.

·         The Company issued 19,469 shares upon exercise of certain outstanding warrants;

 

During the fiscal year ended March 31, 2014 the Company had the following issuances of capital stock:

 

·         The Company issued 1,000,000 shares of common stock for the indemnification of a legal settlement to two members of our Board of Directors.

·         The Company issued 527,500 shares of common stock as partial compensation to three firms in connection with capital raising activities.

·         The Company issued 1,000,000 shares of common stock in lieu of cash payments of $164,000 for previous legal services provided to the Company.

·         The Company issued 375,000 shares of common stock to Theo Strous, a member of the Company’s Board of Directors for his participation on a Special Litigation Committee of the Board of Directors

·         The Company issued 100,000 shares of common stock to Laurence Zipkin, an unaffiliated third party for his participation on a Special Litigation Committee of the Board of Directors

 

The Company had 50,739,312 shares of common stock issued and outstanding as of March 31, 2014 of which 1,000,000 were held in treasury.

 

As of March 31, 2014, the Company had 5,566,795 warrants outstanding.  425,545 warrants have exercise prices of $.70 per share and expire in 2016 and 2017.  The warrants were issued by the Company as compensation for consulting work, placement agent services, and in exchange for cash discounts on facility rent and are valued at $0.52 per warrant using the Black-Scholes option pricing model.  The Company had 4,891,250 of warrants outstanding with exercises prices of $1.60 that expire in 2015.  These warrants were issued as part of the units issued during the year ended March 31, 2013.  In addition, during the fiscal year ended March 31, 2013, the Company issued 200,000 warrants which remain outstanding with an exercise price of $1.60 that expire in 2018 in exchange for consulting services and are valued at $0.57 per warrant using the Black-Scholes option pricing model.  During the fiscal year ended March 31, 2014, the Company issued 50,000 warrants at an exercise price of $0.37 that remain outstanding and which expire in 2018 in exchange for consulting services and are valued at $0.28 per share using the Black-Scholes option pricing model.

 

SHARE-BASED COMPENSATION
SHARE-BASED COMPENSATION

 

 

NOTE 6 — SHARE-BASED COMPENSATION

 

The Company currently has one equity-based compensation plan under which stock-based compensation awards can be granted to directors, officers, employees and consultants providing bona fide services to or for the Company.  The Company’s 2012 Share Incentive Plan was adopted on May 7, 2012 (the “2012 Share Incentive Plan” or “Plan”) and allows the Company to issue up to 5,000,000 shares of its common stock pursuant to awards granted under the 2012 Share Incentive Plan.  The Plan permits the granting of stock options, stock appreciation rights, restricted or unrestricted stock awards, phantom stock, performance awards, other stock-based awards, or any combination of the foregoing.  The only awards that have been issued under the Plan are stock options.  Because the Plan has not been approved by our shareholders, all such stock option awards are non-qualified stock options.  The following sets forth the options to purchase shares of the Company’s stock issued and outstanding as of March 31, 2014:

 

Options 

 

Shares

 

Weighted-
Average Exercise
Price

 

Weighted-Average
Remaining
Contractual Term

 

Options Outstanding April 1, 2012

 

 

$

 

 

Granted

 

11,417,500

 

0.85

 

 

Exercised

 

 

 

 

Expired/Cancelled

 

(7,325,000

)

0.84

 

 

Options Outstanding March 31, 2013

 

4,092,500

 

$

0.87

 

2.29

 

Granted

 

706,250

 

0.36

 

 

Exercised

 

 

 

 

Expired/cancelled

 

(456,250

)

0.73

 

 

Options Outstanding March 31, 2014

 

4,342,500

 

$

0.77

 

1.75

 

Exercisable at March 31, 2014

 

1,927,708

 

$

0.77

 

1.63

 

 

The intrinsic value of options outstanding and of options exercisable at March 31, 2014 and 2013 was $0 and $299,900, respectively.

 

A summary of the status of non-vested shares as of March 31, 2014 and changes during the year ended March 31, 2014 is presented below.

 

 

 

 

 

Weighted Average

 

 

 

 

 

Grant-Date

 

Non-vested Shares

 

Shares

 

Fair Value

 

Non-vested at April 1, 2012

 

 

$

 

Granted

 

11,417,500

 

0.59

 

Vested

 

(3,626,333

)

0.55

 

Expired/cancelled: non-vested

 

(5,325,000

)

0.59

 

Non-vested at March 31, 2013

 

2,466,167

 

0.65

 

Granted

 

706,250

 

0.22

 

Vested

 

(575,625

)

0.45

 

Expired/cancelled: non-vested

 

(182,000

)

0.38

 

Non-vested at March 31, 2014

 

2,414,792

 

$

0.49

 

 

The following table summarizes information about stock options outstanding by price range as of March 31, 2014:

 

 

 

Options Outstanding

 

Options Exercisable

 

Range of
Exercise Price

 

Number
Outstanding

 

Weighted Average
Remaining
Contractual Life
(years)

 

Weighted Average
Exercise Price

 

Number of
Shares

 

Weighted Average
Exercise Price

 

$0.83 - $1.02

 

2,343,750

 

1.88

 

$

0.91

 

885,333

 

$

0.92

 

$0.70 - $0.80

 

1,342,500

 

1.17

 

0.72

 

818,500

 

0.71

 

$0.33 - $0.42

 

656,250

 

2.49

 

0.36

 

223,875

 

0.41

 

 

 

4,342,500

 

1.75

 

$

0.77

 

1,927,708

 

$

0.77

 

 

On March 25, 2013, the Board of Directors authorized the issuance of 500,000 shares of the Company’s common stock to Edward S. Adams, former Chairman of the Board, and 500,000 shares of the Company’s common stock to Michael R. Monahan, a former member of the Board, to indemnify Messrs. Adams and Monahan under applicable law and the Company’s charter documents for shares of Company common stock transferred by them in May 2012 to certain individuals in settlement of a complaint filed by such individuals against Messrs. Adams and Monahan, their respective spouses, the law firm of Adams Monahan LLP, Mr. Joseph Lancia (our former President and Chief Executive Officer), the Company, and, as a nominal defendant, Private Scio.  The Company valued the shares issued to Messrs. Adams and Monahan at the then market value of $0.83 per share and recognized $830,000 as professional and consulting fees related to this authorization for indemnity during the fiscal year ended March 31, 2013.  These shares were issued by the Company during the fiscal year ended March 31, 2014.

 

On September 25, 2013, the Company granted nine non-executive employees options to purchase a total of 500,000 shares of the Company’s stock.  These options vest based on the Company meeting various operating metric and cash flow targets.  The exercise price of $0.33 per share is equal to the closing price of a share of the Company’s common stock on the date of grant.  Using the Black-Scholes option pricing model, management has estimated the options issued on September 25, 2013 had a value of $0.21 per option on the date of the grant.  The Black-Scholes model assumptions used were: Expected dividend yield, 0.00%; Risk-free interest rate, 0.66%; Expected life in years, 3.0; Expected volatility, 102.3%.  None of these options were vested upon issuance.  Subsequent to issuance, a portion of these options have vested and the Company has recognized $5,312 in compensation costs for these options in the fiscal year ending March 31, 204.

 

On October 1, 2013, the Company’s Board of Directors approved the issuance of options to purchase 68,750 shares of common stock to each of our former board members Messrs. Adams, Linares, and Strous for their services to date through calendar 2013.  Each grant is in accordance with the Company’s director compensation program that provides for the grant of options to purchase 6,250 shares of common stock to each director for each Board meeting held.  All 206,250 options issued have an exercise price of $0.42 that reflects the Company’s closing stock price on the date of grant.  Using the Black-Scholes option pricing model, management has determined the options issued on October 1, 2013 had a value of $0.26 per option on the date of grant.  The Black-Scholes model assumptions used were: Expected dividend yield, 0.00%; Risk-free interest rate, 0.66%; Expected life in years, 3.0; Expected volatility, 102.3%.  Total compensation costs of $54,429 have been recognized for these options during the fiscal year ended March 31, 2014.

 

For the years ended March 31, 2014 and 2013, the Company recognized $193,150 and $1,996,426, respectively, as compensation cost for options issued, and recorded related deferred tax asset of $0 for all periods.

 

At March 31, 2014, unrecognized compensation expense related to non-vested awards was $1,120,222.  This cost is expected to be recognized over a weighted average period of 1.85 years.  The total fair value of shares vested during the years ended March 31, 2014 and 2013 was $258,512 and $1,873,609, respectively.

 

OTHER INCOME AND EXPENSE
OTHER INCOME AND EXPENSE

 

 

NOTE 7 — OTHER INCOME AND EXPENSE

 

For the fiscal year ended March 31, 2014, the Company recognized $161,439 in interest expense related to its outstanding note payable.

 

The Company recognized $12,522 in other income for the forgiveness of interest expense for the period ended March 31, 2013.

 

OPERATING LEASES
OPERATING LEASES

 

 

NOTE 8 — OPERATING LEASES

 

During the fiscal year ended March 31, 2014, the Company leased office space at locations in Hudson, Massachusetts and Greenville, South Carolina. Under the terms of the leases, the Company is obligated to pay escalation rentals for certain operating expenses and real estate taxes. The Company’s lease in Hudson, Massachusetts expired in January 2014 and the Greenville, South Carolina lease expires in March 2019.  The Company leases electrical equipment in its production facility in South Carolina with these leases expiring during the 2016 fiscal year. The Company also leases two automobiles with lease expirations in fiscal 2015.

 

The Company recognizes lease expense on a straight-line basis and recognized $421,038 and $426,023 in lease expense for the fiscal years ending March 31, 2014 and 2013, respectively.  The Company has other liabilities consisting of deferred rent payable of $84,144 and $50,195 at March 31, 2014 and 2013, respectively.  Minimum future rental payments under the leases are summarized as follows:

 

2015

 

$

383,134

 

2016

 

347,851

 

2017

 

361,660

 

2018

 

224,410

 

2019

 

224,410

 

2020 and thereafter

 

$

224,411

 

 

RELATED PARTIES
RELATED PARTIES

 

 

NOTE 9 — RELATED PARTIES

 

The Company incurred expenses of $19,658 and $106,229 for professional and consulting services provided by Adams Monahan, LLP, a firm in which our former board member, Edward S. Adams and Michael R. Monahan were partners, for the years ended March 31, 2014 and 2013, respectively.  The Company and Adams Monahan LLP terminated their professional relationship on June 30, 2013.

 

On March 6, 2013, the Board of Directors retained two then directors, Mr. Michael Monahan and Mr. Theo Strous, to provide consulting services for the Company at a total cost of $11,000 and $4,000 respectively, per month.  The Company recognized $15,000 in consulting expense for these services during the fiscal year ended March 31, 2013 and $45,000 during the fiscal year ended March 31, 2014. These consulting service agreements with both Messrs. Monahan and Strous were terminated effective June 30, 2013.

 

On March 25, 2013, the Board of Directors reviewed the facts of previous litigation that was settled in May 2012 and agreed that the Company should accept liability for the settlement and authorized the following to indemnify Messrs. Adams and Monahan, then members of the Board, under applicable law and the Company’s charter documents for expenses incurred and shares of Company common stock and cash transferred by them in settlement of the litigation:  (i) the issuance of 500,000 shares of the Company’s common stock to each of Messrs. Adams and Monahan, (ii) the payment of $90,000 to Mr. Adams for amounts paid by him to settle the complaint, and (iii) any other amounts and expenses paid in connection with stockholder litigation matters involving certain current and former stockholders of the Company.

 

During the fiscal year ended March 31, 2013, the Company recognized $946,555 in expense related to the foregoing indemnification.  Of this amount, $830,000 represents non-cash expenses related to the value of the Company common stock to be issued.  On May 21, 2013, the Company issued the 1,000,000 shares previously allocated for indemnification of Messrs. Adams and Monahan and on July 2, 2013, the Company entered into an agreement with Mr. Adams to pay out remaining indemnification related liabilities of $117,305.93 at $7,500 per month through October 2014.

 

On May 14, 2013, the Board of Directors created a special committee consisting of then board member Mr. Theo Strous to evaluate a report to the Board of Directors by former counsel to the Company and certain actions of a former member of the Board of Directors and former company officers. The report was completed at the end of June 2013. The Board of Directors approved the payment of $25,000 to Mr. Strous as compensation for his service on the special committee.

 

On January 6, 2014, the Board of Directors created a Special Litigation Committee (“SLC”) to consider the merits of shareholder allegations made in ongoing litigation.  The Board appointed the current board member Mr. Theo Strous and Mr. Laurence Zipkin, an unaffiliated third party, to the SLC.  Each member of the committee received at their election a one-time payment of $50,000 plus 100,000 shares of common stock or shares in lieu of such cash and share amount in the amount of 375,000 shares upon completion of the investigation.  The SLC delivered their report to the Board of Directors on March 25, 2014.  Mr. Strous elected to receive his payment in company stock while Mr. Zipkin elected to receive $50,000 in cash plus 100,000 shares.  During the fiscal year ended March 31, 2014, the Company recognized $93,750 in consulting expense for the shares issued to Mr. Strous and $168,750 in total consulting expenses for the SLC.

 

As of March 31, 2104, the Company had $215,306 in related party liabilities.

 

INCOME TAXES
INCOME TAXES

 

 

NOTE 10 — INCOME TAXES

 

There was no current or deferred tax expense (benefit) for the years ended March 31, 2014 and 2013.

 

The deferred tax asset (liability) at March 31, 2014 and 2013 consists of the following types of temporary differences and their related tax effects:

 

 

 

At March 31,
2014

 

At March 31,
2013

 

Accrued expenses

 

$

235,998

 

$

187,640

 

Property and equipment

 

(150,810

)

(112,563

)

Impairment of fixed assets

 

142,767

 

 

 

Capitalized startup/acquisition costs

 

499,288

 

633,713

 

Federal and state net operating loss carry-forward

 

3,857,269

 

2,122,402

 

Trade name

 

 

92,572

 

Intangible assets

 

14,537

 

(55,685

)

Nonqualified options and warrants granted for services

 

 

59,029

 

 

 

 

 

 

 

Valuation allowance

 

(4,599,049

)

(2,927,108

)

Total

 

$

 

$

 

 

The Company recorded a valuation allowance against its net deferred tax asset at March 31, 2014 and March 31, 2013, as the Company believes that it is more likely than not that this asset will not be realized.

 

 

 

At March 31, 2014

 

At March 31, 2013

 

 

 

Amount

 

%

 

Amount

 

%

 

Tax at statutory federal income tax rate

 

$

(1,683,324

)

(34.0

)%

$

(2,476,000

)

(34.0

)%

Increase (decrease) resulting from:

 

 

 

 

 

 

 

 

 

State income tax expense

 

 

0.0

%

 

0.0

%

Change in valuation allowance

 

1,671,941

 

33.8

%

1,846,204

 

25.3

%

Incentive stock options

 

 

0.0

%

625,235

 

8.6

%

Other, net

 

11,383

 

0.2

%

4,561

 

0.1

%

 

 

 

 

 

 

 

 

 

 

Total

 

$

 

0.0

%

$

 

0.0

%

 

The Company had federal and state net operating loss carry-forwards (“carry-forward”) of $10,231,000 and $5,646,000 at March 31, 2014 and 2013 respectively.  These carry-forwards start to expire in the year 2031.

 

INVESTMENT IN JOINT VENTURE
INVESTMENT IN JOINT VENTURE

 

 

NOTE 11 — INVESTMENT IN JOINT VENTURE

 

On September 16, 2013, the Company entered into a series of agreements with SAAMABA, LLC (“SAAMABA”) and S21 Research Holdings (the “Grace Rich Agreements”) to form a joint venture with operations in the People’s Republic of China (“PRC”) to deploy a minimum of 100 Company designed diamond growing machines.  Through the Grace Rich Agreements, the Company owns 30% of Grace Rich LTD, a corporation duly established pursuant to the laws of the Hong Kong Special Administrative Region of the PRC that is an investment and holding company for the factory and distribution center to be formed pursuant to the laws of the PRC as a wholly foreign owned enterprise.

 

Under the Grace Rich Agreements, the Company has agreed to license its proprietary technology for the manufacture of diamond gemstones of agreed upon specifications.  In exchange for the license, the Company will receive licensing revenue and 30% ownership in the joint venture.  In addition to the licensed technology, the Grace Rich Agreements include obligations for the Company to provide and be compensated for technology consulting services to the joint venture to support the start-up of operations.

 

The initial ownership interests in Grace Rich Limited are as follows:  SAAMABA LLC- 60%; Scio Diamond Technology Corporation — 30% and S21 Holdings- 10%.  The capital contributions required to finance Grace Rich LTD are requirements of SAAMABA, and the Company is not required to make any on-going funding contributions to the joint venture and its ownership stake cannot be reduced from 30%.

 

The Company is licensing a portion of its patented technology to Grace Rich LTD and is not directly contributing any of its intellectual property.  The license agreement calls for the Company to receive $250,000 in licensing fees and $750,000 in development fees between October 2013 and June 2014.  In addition, once operations of Grace Rich LTD have commenced, the Company will receive $250 per machine per month in licensing fees with a minimum monthly payment of $25,000 until the joint venture starts to distribute cash to its partners.

 

The Company has determined the fair value of the license agreement does not exceed the value of the expected returns from the joint venture and accordingly has established an initial investment value of $0 and has not recorded any gains related to its contribution to the joint venture.  The Company joint venture was in its development stage through March 31, 2014 and did not have any revenues.  Expenses incurred by the joint venture were for planning and startup expenses.  The total loss of the joint venture from inception through March 31, 2014 was $1,043, 945. The Company’s corresponding 30% share of these losses was $313,184.

 

As of March 31, 2014, the Company has not guaranteed obligations of the joint venture nor has it committed to provide additional funding. Therefore, the Company’s share of the joint venture’s net loss for the year ended March 31, 2014 were not recognized because the initial carrying value of the Company’s ownership interest in the joint venture was zero.

 

Rollforward of the Company’s ownership interest in the joint venture for the year ended March 31, 2014:

 

Balance of ownership interest in joint venture at September 16, 2013

 

$

 

Aggregate 2014 equity loss — share of joint venture losses

 

(313,184

)

2014 equity loss — share of joint venture losses not recognized due to basis limitation

 

313,184

 

Balance of ownership interest in joint venture at March 31, 2014

 

$

 

 

 

 

 

Cumulative unrecognized loss on ownership interest in joint venture at March 31, 2014

 

$

(313,184

)

 

Selected financial results for Grace Rich LTD from inception through March 31, 2014 are as follows:

 

Revenues

 

$

 

Expenses

 

1,043,945

 

Net Income (Loss)

 

$

(1,043,945

)

 

 

 

 

Total Assets

 

$

68,297

 

 

 

 

 

Total Liabilities

 

$

1,112,242

 

Total Partners Capital

 

(1,043,945

)

Total Liabilities and Partner Capital

 

$

68,297

 

 

The Company recognized $625,000 in revenues from Grace Rich during the fiscal year ended March 31, 2014. The Company incurred $151,359 of joint venture related expenses during the fiscal year ended March 31, 2014 that were reimbursed by the Grace Rich LTD.  These reimbursements were offset against the Company’s related operating expense.

 

LITIGATION
LITIGATION

 

 

NOTE 12 — LITIGATION

 

On July 26, 2013, Bernard M. McPheely, Trustee for the Bernard M. McPheely Revocable Trust Dated May 25, 2012, Thomas P. Hartness, Trustee for the Thomas P. Hartness Revocable Trust Dated July 31, 2010, Brian McPheely and Robert Daisley (collectively, “Plaintiffs”), derivatively and on behalf of the Company, filed a complaint in the Court of Common Pleas of the State of South Carolina, County of Greenville against Edward S. Adams (then our Chairman), Michael R. Monahan (a former member of the Company’s Board of Directors), Robert Linares (a then current member of the Board), Theodorus Strous (a then current member of the Board) and the law firm of Adams Monahan, LLP (collectively, “Defendants”), and the Company, as a nominal defendant (the “Scio Derivative Complaint”).  Bernard M. McPheely is a former member of the Company’s Board of Directors.

 

The Scio Derivative Complaint alleged (i) against Defendants, breach of fiduciary duty, corporate waste and unjust enrichment; (ii) against Messrs. Strous and Linares and Adams Monahan LLP, aiding and abetting a breach of fiduciary duty; (iii) against Messrs. Adams and Monahan, civil conspiracy; (iv) against Messrs. Adams, Monahan and Linares, breach of fiduciary duty — controlling shareholder; and (v) against Mr. Strous and Adams Monahan LLP, aiding and abetting a breach of controlling shareholder duty.  The allegations relate to, among other things, certain actions allegedly taken by defendants in connection with: the acquisition by the Company of certain assets of ADI (the “ADI Asset Purchase”); the ADGC Asset Purchase discussed in Note 2 above; the Company’s agreement to provide certain current and former stockholders of ADI and ADGC the opportunity to acquire up to approximately 16 million and 1 million shares, respectively, of common stock of the Company for $0.01 per share (collectively, the “ADI/ADGC Offering”); the provision of legal services by Adams Monahan LLP to the Company; certain equity issuances by the Company following the ADI/ADGC Offering; certain bonuses and other payments paid to members of the Board of Directors; and certain indemnification obligations undertaken by the Company in favor of Messrs. Adams and Monahan.

 

Plaintiffs were seeking direct and consequential damages sustained by the Company in an amount to be established through proof at trial, plus pre-judgment and post-judgment interest; appropriate equitable relief to remedy the alleged breaches of fiduciary duties; reasonable attorney’s fees and costs for the Company incurred in prosecuting the action; and other relief as deemed by the court to be just and proper.

 

Defendants removed the Scio Derivative Complaint to the U.S. District Court for the District of South Carolina, Greenville Division (the “Federal Court”) and filed a motion to dismiss the complaint on October 4, 2013.  On December 16, 2013, the Federal Court granted the Defendants’ motion to dismiss, in part based on the plaintiffs’ lack of standing, and the remaining claims were dismissed by the court without prejudice in favor of mandatory arbitration proceedings.  As of March 31, 2014, arbitration proceedings had not commenced.

 

On October 15, 2013, plaintiff Mark P. Sennott, as Trustee of the Sennott Family Charitable Trust, (“Sennott”) filed a complaint derivatively, on behalf of ADI, in the Federal Court, against Edward S. Adams (our then Chairman), Michael R. Monahan (a former member of the Company’s Board of Directors), the law firm of Adams Monahan, LLP, Loblolly, Inc., which was formerly known as Scio Diamond Technology Corporation, and the Company (collectively, “Sennott Defendants”).  This derivative complaint on ADI’s behalf (the “ADI Derivative Complaint”) alleges claims for breach of fiduciary duty, constructive fraud and unjust enrichment.  The allegations in the ADI Derivative Complaint are duplicative of the Scio Derivative Complaint allegations concerning ADI, which were dismissed by the Federal Court’s December 16, 2013 order in the Scio Derivative Complaint and repeat almost verbatim the allegations from earlier lawsuits filed and dismissed in 2012 against the Defendants, which were previously disclosed in the Company’s Form 10-Q for the nine months ended December 31, 2012 and Form 10-K for fiscal year ended March 31, 2013.  Sennott is seeking direct and consequential damages sustained by Sennott in an amount to be established through proof at trial, plus pre-judgment and post-judgment interest; appropriate equitable relief to remedy the allegedly wrongful acts; reasonable attorney’s fees and costs incurred in prosecuting the action; and other relief as deemed by the court to be just and proper.

 

Both the Scio Derivative Complaint and the ADI Derivative Complaint were effectively settled on June 23, 2014 as detailed in NOTE 13- SUBSEQUENT EVENTS below.

 

On May 16, 2014 the Company received a subpoena issued by the SEC ordering the provision of documents and related information concerning various corporate transactions between the Company and its predecessors and other persons and entities.  The Company is fully cooperating with this inquiry.

 

SUBSEQUENT EVENTS
SUBSEQUENT EVENTS

 

 

NOTE 13 — SUBSEQUENT EVENTS

 

On April 8, 2014, the Board of Directors of the Company adopted and approved effective April 8, 2014, the Amended and Restated Bylaws of Scio Diamond Technology Corporation. The Amended and Restated Bylaws amend and restate the Company’s bylaws in their entirety.

 

At the request of the Board of Directors, the Company entered into an agreement, effective April 12, 2014, with Mr. Joseph Cunningham to provide consulting services to the Company.  Under this agreement, the Company agreed to provide Mr. Cunningham $4,000 and 20,000 shares of common stock per month in exchange for his professional services to the Company.  Through June 30, 2014, the Company had issued 60,000 shares to Mr. Cunningham.  These shares were valued at an average of $0.44 and the Company will recognize $26,200 in expense for these shares.

 

On April 15, 2014, Scio Diamond Technology Corporation (the “Company”) entered into a Rights Agreement between the Company and Empire Stock Transfer Inc., as Rights Agent (as amended from time to time, the “Rights Agreement”) that was previously approved by the Board of Directors of the Company.

 

In connection with the Rights Agreement, a dividend was declared of one common stock purchase right (individually, a “Right” and collectively, the “Rights”) for each share of common stock, par value $0.001 per share (the “Common Stock”), of the Company outstanding at the close of business on April 25, 2014 (the “Record Date”).  Each Right entitled the registered holder thereof, after the Rights become exercisable and until April 15, 2017 (or the earlier redemption, exchange or termination of the Rights), to purchase from the Company one share of Common Stock of the Company at a price of $1.20 per share of Common Stock (the “Purchase Price”).  Until the earlier to occur of (i) the close of business on the tenth business day following a public announcement that a person or group of affiliated or associated persons has acquired, or obtained the right to acquire, beneficial ownership of 17% or more of the Common Stock (an “Acquiring Person”) or (ii) the close of business on the tenth business day (or such later date as may be determined by action of the Board of Directors prior to such time as any person or group of affiliated or associated persons becomes an Acquiring Person) following the commencement or announcement of an intention to make a tender offer or exchange offer the consummation of which would result in the beneficial ownership by a person or group of affiliated or associated persons of 17% or more of the Common Stock (the earlier of (i) and (ii) being called the “Distribution Date”), the Rights will be evidenced, with respect to any of the Common Stock certificates outstanding as of the Record Date, by such Common Stock certificates, or, with respect to any uncertificated Common Stock registered in book entry form, by notation in book entry, in either case together with a copy of the Summary of Rights attached as Exhibit B to the Rights Agreement.  Under the Rights Agreement, synthetic ownership of Common Stock in the form of derivative securities counts towards the 17% ownership threshold, to the extent actual shares of Common Stock equivalent to the economic exposure created by the derivative security are directly or indirectly beneficially owned by a counterparty to such derivative security.

 

The Rights Agreement provided that any person who beneficially owned 17% or more of the Common Stock immediately prior to the first public announcement of the adoption of the Rights Agreement, together with any affiliates and associates of that person (each an “Existing Holder”), shall not be deemed to be an “Acquiring Person” for purposes of the Rights Agreement unless an Existing Holder becomes the beneficial owner of one or more additional shares of Common Stock (other than pursuant to a dividend or distribution paid or made by the Company on the outstanding Common Stock in Common Stock or pursuant to a split or subdivision of the outstanding Common Stock).  However, if upon acquiring beneficial ownership of one or more additional shares of Common Stock, the Existing Holder does not beneficially own 17% or more of the Common Stock then outstanding, the Existing Holder shall not be deemed to be an “Acquiring Person” for purposes of the Rights Agreement.  On June 22, 2014, the Board of Directors accelerated the expiration date of the Rights to June 22, 2014 and the Rights effectively terminated.

 

On May 27, 2014, the Board of Directors appointed Mr. James Korn and Mr. Gerald McGuire as independent members to the Board.  Each of Messrs. Korn and McGuire were provided 250,000 shares of restricted stock upon their appointment to the Board.

 

On June 12, 2014, the Board of Directors decided to terminate without cause the employment of Chief Executive Officer, Michael McMahon and Chief Financial Officer, Jonathan Pfohl.  The Board named then Board Member Gerald McGuire as interim Chief Executive Officer and appointed Douglas Walker as interim Chief Financial Officer.  The Board also named Michael Laub as Chief Restructuring Officer.

 

On June 16, 2014, the Board of Directors appointed Bruce Likly as a member of Board and further appointed Mr. Likly to serve as the Co-Chairman of the Board.  Mr. Likly was provided with a restricted share grant of 4,000,000 shares upon his appointment to the Board.

 

On June 20, 2014, the Board of Directors granted restricted stock grants to Mr. Michael Laub of 50,000 shares for previously performed services rendered to the Company.  The Company does not anticipate recognizing any expense for this restricted stock grant since it was in exchange for expenses previously accrued by the Company.

 

In addition, on June 20, 2014, the Company’s $1.5 million loan facilities with Platinum went into default status.  In default status, Platinum could foreclose on the loan and has the right to take possession of the collateral including the Company’s fixed assets and intellectual property.  In addition, in default status, Platinum has the right to increase the interest rate on the note by 3% upon 30 day notice to the Company.  To date, Platinum has not taken any action related to this default, including adjusting the interest rate, as the Company continues to pursue additional financing alternatives.

 

On June 23, 2014, the Company entered into a settlement agreement (the “Settlement Agreement”) by and among Edward Adams, Michael Monahan, Gerald McGuire, James Korn, Bruce Likly, Theodorus Strous, and Robert C. Linares, their present and past affiliates, such as Apollo Diamond, Inc., Apollo Diamond Gemstone Corporation, Adams Monahan LLP, Focus Capital Group, Inc. and Oak Ridge Financial Services Group, Inc., family members and spouses (the “Adams Group”), and Thomas P. Hartness, Kristoffer Mack, Paul Rapello, Glen R. Bailey, Marsha C. Bailey, Kenneth L. Smith, Bernard M. McPheely, James Carroll, Robert M. Daisley, Ben Wolkowitz, Craig Brown, Ronnie Kobrovsky, Lewis Smoak, Brian McPheely, Mark P. Sennott, the Sennott Family Charitable Trust, and their affiliates (the “Save Scio Group”),  pursuant to which the Company and the Save Scio Group settled the previously pending consent contest for the election of directors. Pursuant to the Settlement Agreement, on June 23, 2014, Messrs. Adams, Strous, Linares and McGuire resigned as directors effective immediately; the Board expanded the size of the Board to 7 directors and appointed Messrs. McPheely, Wolkowitz, Smoak and Leaverton (the “Save Scio Nominees”) to fill all sbut one of the resulting vacancies. In addition, the Company agreed to nominate each of Messrs. Korn and Likly (the “Adams Group Nominees”) and the Save Scio Nominees for election to the Board at the Company’s 2014 annual meeting of stockholders. Pursuant to the Settlement Agreement, the Adams Group and the Save Scio Group must vote their shares of Common Stock for the other’s nominees for the next three years, and will also have replacement rights in the event these nominees are unable to serve as directors.

 

The Settlement Agreement contains various other terms and provisions, including with respect to the transfer of one million shares of Common Stock to the Save Scio Group by the Adams Group, a portion of which is allocated for reimbursement of the Save Scio Group’s out-of-pocket expenses in connection with the nomination of the Save Scio Nominees and past litigation involving certain members of the Adams Group and the Save Scio Group (the Scio Derivative Complaint and the ADI Derivative Complaint collectively known as the “Litigation”), the Save Scio Group’s withdrawal of the Litigation, termination of the Save Scio Group’s consent solicitation, and accelerated expiration of the Company’s stockholder Rights Agreement adopted on April 15, 2014. Also included in the settlement is the forfeiture of one million shares of common stock by Messrs. Edward Adams and Michael Monahan for cancellation by Scio.

 

Concurrent with the Settlement Agreement, the equity granted to Messrs. Korn, Likly, and McGuire for their service on the Board of Directors consisting of 250,000, 4,000,000 and 250,000 restricted shares, respectively was returned to the Company.  In addition, all equity granted and contemplated to be granted to Messrs. McGuire, Walker and Laub for their services as executive officers of the Company was effectively returned to the Company.  The Company does not plan to recognize any expense for the restricted shares granted and returned to the Company since none of the grants had vested at the time of their return to the Company.

 

In addition, the Settlement agreement provides for the release of all liabilities amongst the parties.  The Company estimates that this will result in the reversal of over $340,000 of past accrued liabilities and expenses due to the settling parties for board fees, management committee fees, consulting services, indemnification of board members and legal expenses.

 

On June 24, 2014, the Board of Directors named Mr. Bernard M. McPheely Chairman and Bruce Likly Vice-Chairman.

 

On July 11, 2014, the Board of Directors named Gerald McGuire, President, Chief Executive Officer and Director of the of the Company.

 

On July 15, 2014, the Board of Directors approved the Company pursue a Regulation D offering of up to 2,000,000 shares of common stock to accredited investors at a price of $0.30.  The Company may raise up to $600,000 from this offering and does not anticipate incurring any material expenses related to the offering.  Through August 8, 2014, the Company has issued 750,000 shares under this offering and raised $225,000.

ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

 

Going Concern

 

The Company has generated very little revenue to date and consequently its operations are subject to all risks inherent in the establishment and commercial launch of a new business enterprise.

 

These factors raise substantial doubt about the Company’s ability to continue as a going concern. Management has responded to these circumstances by taking the following actions:

 

·         On-going solicitation of investment in the Company in the form of private placements of common shares, secured and unsecured debt to accredited investors;

·         Focused efforts on new business development opportunities to generate revenues and diversify our customer base;

·         Enhanced efforts on optimizing production for existing manufacturing capabilities; and

·         Continued to explore strategic joint ventures, technology licensing agreements and dedicated contract manufacturing to expand company revenue and cash flow, including our recently agreed to joint venture in China.

 

In the opinion of management, these actions will be sufficient to provide the Company with the liquidity it needs to meet its obligations and continue as a going concern. There can be no assurance, however, that the Company will successfully implement these plans. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

 

Accounting Basis

 

The financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and the disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates, including those related to revenue recognition, provision for doubtful accounts, sales returns, provision for inventory obsolescence, fair value of acquired intangible assets, useful lives of intangible assets and property and equipment, employee stock options, and contingencies and litigation, among others. The Company generally bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual amounts recorded could differ materially from those estimates

 

In accordance with Accounting Standards Codification (“ASC”) 323, Investments—Equity Method and Joint Ventures, the Company uses the equity method of accounting for investments in corporate joint ventures for which the Company has the ability to exercise significant influence but does not control and is not the primary beneficiary. Significant influence typically exists if the Company has a 20% to 50% ownership interest in the venture unless predominant evidence to the contrary exists. Under this method of accounting, the Company records its proportionate share of the net earnings or losses of equity method investees and a corresponding increase or decrease to the investment balances. Cash payments to equity method investees such as additional investments, loans and advances and expenses incurred on behalf of investees, as well as payments from equity method investees such as dividends, distributions and repayments of loans and advances are recorded as adjustments to investment balances. When the Company’s carrying value in an equity method investee is reduced to zero, no further losses are recorded in the Company’s financial statements unless the Company guaranteed obligations of the equity method investee or has committed additional funding.  When the equity method investee subsequently reports income, the Company will not record its share of such income until it equals the amount of its share of losses not previously recognized.  The Company evaluates its equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts of such investments may not be recoverable.

 

 

Fair Value of Financial Instruments

 

The carrying value of cash and cash equivalents,  accounts payable and notes payable approximate their fair value due to the short-term nature of these instruments.

 

Cash and Cash Equivalents

 

For purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with an original maturity of three months or less when purchased to be cash equivalents.  At March 31, 2014 and 2013, the Company held no cash equivalents.

 

 

Basic and Diluted Net Loss per Share

 

Net loss per share is presented under two formats: basic net loss per common share, which is computed using the weighted average number of common shares outstanding during the period, and diluted net loss per common share, which is computed using the weighted average number of common shares outstanding, and the weighted average dilutive potential common shares outstanding, computed using the treasury stock method. Currently, for all periods presented, diluted net loss per share is the same as basic net loss per share as the inclusion of weighted average shares of common stock issuable upon the exercise of options and warrants would be anti-dilutive.

 

The following table summarizes the number of securities outstanding at each of the periods presented, which were not included in the calculation of diluted net loss per share as their inclusion would be anti-dilutive:

 

 

 

March 31,

 

 

 

2014

 

2013

 

Common stock options and warrants

 

9,909,295

 

9,609,295

 

 

 

Allowance for Doubtful Accounts

 

An allowance for uncollectible accounts receivable is maintained for estimated losses from customers’ failure to make payment on accounts receivable due to the Company. Management determines the estimate of the allowance for uncollectible accounts receivable by considering a number of factors, including: (1) historical experience, (2) aging of accounts receivable and (3) specific information obtained by the Company on the financial condition and the current credit worthiness of its customers. The Company also maintains a provision for estimated returns and allowances based upon historical experience.  The Company has determined that an allowance was not necessary at March 31, 2014 or 2013.

 

 

Other Receivables

 

As of March 31, 2014, the Company considered a pending insurance settlement over the actions of a Company supplier of $89,192 as an other receivable.  This settlement was agreed to but not paid at March 31, 2014.

 

 

Inventories

 

Inventories are stated at the lower of average cost or market. The carrying value of inventory is reviewed and adjusted based upon slow moving and obsolete items. Inventory costs include material, labor, and manufacturing overhead and are determined by the “first-in, first-out” (FIFO) method.  The components of inventories are as follows:

 

 

 

March 31,
2014

 

March 31,
2013

 

Raw materials and supplies

 

$

35,543

 

$

64,255

 

Work in process

 

25,611

 

 

Finished goods

 

91,663

 

474,693

 

 

 

$

152,817

 

$

538,948

 

 

During the fiscal year ended March 31, 2014, we recorded a lower cost of market write down for inventory of $100,557 due to expected selling prices being lower than cost.  The estimation of the total write-down involves management judgments and assumptions, including assumptions regarding future selling price forecasts, the estimated costs to complete and disposal costs.

 

 

Property, Plant and Equipment

 

Depreciation of property, plant and equipment is on a straight line basis beginning at the time it is placed in service, based on the following estimated useful lives:

 

 

 

Years

 

Machinery and equipment

 

3–15

 

Furniture and fixtures

 

3–10

 

Engineering equipment

 

5–12

 

 

Leasehold improvements are depreciated over the lesser of the remaining term of the lease or the life of the asset (generally three to seven years).

 

Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized. Expenditures for maintenance and repairs are charged to expense as incurred. Manufacturing equipment was placed into service beginning July 1, 2012.  The Company incurred total depreciation expense of $700,690 and $490,136 for the years ended March 31, 2014 and 2013, respectively.

 

During the fiscal year ended March 31, 2014, the Company closed its operations in Hudson, Massachusetts.  With this closing the Company recognized a loss of $129,308 for the disposal of certain fixed assets at the location.  Concurrent with the closing of the Hudson facility, the Company re-evaluated the useful life of certain fixed assets acquired from Apollo Diamond in 2012 and decided that an impairment reserve related to these assets of $381,798 was appropriate.

 

Intangible Assets

 

Intangible assets, such as acquired in-process research and development costs, are considered to have an indefinite useful life until such time as they are put into service at which time they will be amortized on a straight-line basis over the shorter of their economic or legal useful life. Management evaluates indefinite life intangible assets for impairment on an annual basis and on an interim basis if events or changes in circumstances between annual impairment tests indicate that the asset might be impaired. The ongoing evaluation for impairment of its indefinite life intangible assets requires significant management estimates and judgment. Management reviews definite life intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. There are no impairment charges during the years ended March 31, 2014 or 2013.

 

 

Income Taxes

 

Income taxes are accounted for under the asset and liability method. Deferred income taxes reflect the tax consequences on future years of differences between the tax bases of assets and liabilities and their financial reporting amounts. Valuation allowances are provided against deferred tax assets when it is more likely than not that an asset will not be realized in accordance with Accounting Standards Codification (“ASC”) 740, Accounting for Income Taxes.

 

Management has evaluated the potential impact in accounting for uncertainties in income taxes and has determined that it has no significant uncertain income tax positions as of March 31, 2014 or 2013.  Income tax returns subject to review by taxing authorities include March 31, 2010 through March 31, 2014.

 

 

Stock-based Compensation

 

Stock-based compensation for the value of stock options is estimated on the date of the grant using the Black-Scholes option-pricing model. The Black-Scholes model takes into account implied volatility in the price of the Company’s stock, the risk-free interest rate, the estimated life of the equity-based award, the closing market price of the Company’s stock on the grant date and the exercise price. The estimates utilized in the Black-Scholes calculation involve inherent uncertainties and the application of management judgment.

 

 

Concentration of Credit Risk

 

During the year ended March 31, 2014 the Company had 27 different customers.  One customer accounted for 58% of our total product revenue.  For the year ended March 31, 2013, one customer accounted for 84% of total revenues for the Company and purchased substantially all of the Company’s production output. The second customer purchased a substantial portion of the Company’s by-product inventory and accounted for 11% of total revenues for the Company.

 

 

Fair Value Measurement

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy prescribed by the accounting literature contains three levels as follows:

 

Level 1— Quoted prices in active markets for identical assets or liabilities.

 

Level 2— Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3— Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation.

 

In addition, GAAP requires the Company to disclose the fair value for financial assets on both a recurring and non-recurring basis. During June 2012, the Company issued to certain current and former stockholders of Apollo Diamond Gemstone Corporation (“ADGC”) that are accredited investors subscription rights valued at $770,000 for the purchase of ADGC assets disclosed in Note 2 measured at fair value on a nonrecurring basis. The fair value of the ADGC subscription rights was determined using the Black-Scholes model whose assumptions were considered by management to be a Level 3 input.

 

Revenue Recognition

 

We recognize product revenue when persuasive evidence of an arrangement exists, delivery of products has occurred, the sales price is fixed or determinable, and collectability is reasonably assured. For our Company, this generally means that we recognize revenue when we or our fabrication vendor has shipped finished product to the customer. Our sales terms do not allow for a right of return except for matters related to any manufacturing defects on our part.  The Company recognizes licensing and development revenues in accordance with the contractual terms of the agreements.

 

 

Recent Accounting Pronouncements

 

In July 2012, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2012-02, Testing Indefinite-Lived Intangible Assets for Impairment (the revised standard). Under the amendments in this updates, a company has the option first to assess qualitative factors to determine whether the existence of events and circumstances indicates that the it is more likely than not that the indefinite-lived intangible assert is impaired as a basis for determining whether it is necessary to perform the qualitative impairment test in accordance with Topic 350.  The more likely than not threshold is defined as having a likely-hood of more than fifty percent.  If after assessing the qualitative factors, a company determines it does not meet the more likely than not threshold, a company is required to perform the quantitative impairment test by calculating the fair value of an indefinite-lived intangible asset and comparing the fair value with the carrying amount of the asset.  The Amendments in this update are effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. The Company adopted this new standard in the fiscal year ended March 31, 2013 and the adoption did not have a significant impact on its financial statements.

 

In July 2013, the FASB issued ASC 2013-11, “Income Taxes — Presentation of an Unrecognized Tax benefit When a Net Operation Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists”  (“ASU 2013-11”) which is part of Accounting Standards Codification (“ASC”) 740: Income Taxes.  The new guidance requires and entity to present an unrecognized tax benefit and an NOL carryforward, a similar tax loss or a tax credit carryforward on a net basis as part of a deferred tax asset, unless the unrecognized tax benefit is not available to reduce the deferred tax asset component or would not be utilized for that purpose, then a liability would be recognized.  ASU 2013-11 is effective for annual and interim periods for fiscal years beginning after December 15, 2013.  The Company is currently evaluating the impact of the April 1, 2014 adoption of this guidance on its consolidated financial statements.

 

In May 2014, the FASB issued ASU 2014-9 “Revenue from Contracts with Customers (Topic 606).” This guidance requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This guidance is effective for annual reporting periods beginning after December 15, 2016 and early adoption is not permitted. The Company will adopt this standard in fiscal year 2018. The Company has not yet determined the effect, if any, that the adoption of this standard will have on the Company’s financial position or results of operations.

 

There are currently no other accounting standards that have been issued but not yet adopted by the Company that will have a significant impact on the Company’s financial position, results of operations or cash flows upon adoption.

 

ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

 

 

 

 

March 31,

 

 

 

2014

 

2013

 

Common stock options and warrants

 

9,909,295

 

9,609,295

 

 

 

 

 

 

March 31,
2014

 

March 31,
2013

 

Raw materials and supplies

 

$

35,543

 

$

64,255

 

Work in process

 

25,611

 

 

Finished goods

 

91,663

 

474,693

 

 

 

$

152,817

 

$

538,948

 

 

 

 

 

 

Years

 

Machinery and equipment

 

3–15

 

Furniture and fixtures

 

3–10

 

Engineering equipment

 

5–12

 

 

ASSET PURCHASES (Tables) (ADGC Asset Purchase)
Schedule of purchase price allocation of the assets

 

 

Inventory

 

$

269,000

 

In-process research and development

 

601,000

 

Total

 

$

870,000

 

 

INTANGIBLE ASSETS (Tables)

 

 

 

 

 

 

March 31,

 

March 31,

 

 

 

Life

 

2014

 

2013

 

Patents, gross

 

6.75 – 19.46

 

$

8,135,063

 

$

7,543,063

 

In-process research and development

 

Indefinite

 

2,250,435

 

2,851,435

 

 

 

 

 

10,385,498

 

10,385,498

 

Accumulated amortization

 

 

 

(1,144,858

)

(369,847

)

Net intangible assets

 

 

 

$

9,240,640

 

$

10,015,651

 

 

 

 

Fiscal Year Ending

 

 

 

March 31, 2015

 

$

775,011

 

March 31, 2016

 

775,011

 

March 31, 2017

 

775,011

 

March 31, 2018

 

775,011

 

March 31, 2019

 

775,011

 

Thereafter

 

$

3,115,150

 

 

SHARE-BASED COMPENSATION (Tables)

 

 

Options 

 

Shares

 

Weighted-
Average Exercise
Price

 

Weighted-Average
Remaining
Contractual Term

 

Options Outstanding April 1, 2012

 

 

$

 

 

Granted

 

11,417,500

 

0.85

 

 

Exercised

 

 

 

 

Expired/Cancelled

 

(7,325,000

)

0.84

 

 

Options Outstanding March 31, 2013

 

4,092,500

 

$

0.87

 

2.29

 

Granted

 

706,250

 

0.36

 

 

Exercised

 

 

 

 

Expired/cancelled

 

(456,250

)

0.73

 

 

Options Outstanding March 31, 2014

 

4,342,500

 

$

0.77

 

1.75

 

Exercisable at March 31, 2014

 

1,927,708

 

$

0.77

 

1.63

 

 

 

 

 

 

 

 

Weighted Average

 

 

 

 

 

Grant-Date

 

Non-vested Shares

 

Shares

 

Fair Value

 

Non-vested at April 1, 2012

 

 

$

 

Granted

 

11,417,500

 

0.59

 

Vested

 

(3,626,333

)

0.55

 

Expired/cancelled: non-vested

 

(5,325,000

)

0.59

 

Non-vested at March 31, 2013

 

2,466,167

 

0.65

 

Granted

 

706,250

 

0.22

 

Vested

 

(575,625

)

0.45

 

Expired/cancelled: non-vested

 

(182,000

)

0.38

 

Non-vested at March 31, 2014

 

2,414,792

 

$

0.49

 

 

 

 

 

 

Options Outstanding

 

Options Exercisable

 

Range of
Exercise Price

 

Number
Outstanding

 

Weighted Average
Remaining
Contractual Life
(years)

 

Weighted Average
Exercise Price

 

Number of
Shares

 

Weighted Average
Exercise Price

 

$0.83 - $1.02

 

2,343,750

 

1.88

 

$

0.91

 

885,333

 

$

0.92

 

$0.70 - $0.80

 

1,342,500

 

1.17

 

0.72

 

818,500

 

0.71

 

$0.33 - $0.42

 

656,250

 

2.49

 

0.36

 

223,875

 

0.41

 

 

 

4,342,500

 

1.75

 

$

0.77

 

1,927,708

 

$

0.77

 

 

OPERATING LEASES (Tables)
Summary of the minimum future rental payments under the leases

 

 

2015

 

$

383,134

 

2016

 

347,851

 

2017

 

361,660

 

2018

 

224,410

 

2019

 

224,410

 

2020 and thereafter

 

$

224,411

 

 

INCOME TAXES (Tables)

 

 

 

 

At March 31,
2014

 

At March 31,
2013

 

Accrued expenses

 

$

235,998

 

$

187,640

 

Property and equipment

 

(150,810

)

(112,563

)

Impairment of fixed assets

 

142,767

 

 

 

Capitalized startup/acquisition costs

 

499,288

 

633,713

 

Federal and state net operating loss carry-forward

 

3,857,269

 

2,122,402

 

Trade name

 

 

92,572

 

Intangible assets

 

14,537

 

(55,685

)

Nonqualified options and warrants granted for services

 

 

59,029

 

 

 

 

 

 

 

Valuation allowance

 

(4,599,049

)

(2,927,108

)

Total

 

$

 

$

 

 

 

 

 

 

At March 31, 2014

 

At March 31, 2013

 

 

 

Amount

 

%

 

Amount

 

%

 

Tax at statutory federal income tax rate

 

$

(1,683,324

)

(34.0

)%

$

(2,476,000

)

(34.0

)%

Increase (decrease) resulting from:

 

 

 

 

 

 

 

 

 

State income tax expense

 

 

0.0

%

 

0.0

%

Change in valuation allowance

 

1,671,941

 

33.8

%

1,846,204

 

25.3

%

Incentive stock options

 

 

0.0

%

625,235

 

8.6

%

Other, net

 

11,383

 

0.2

%

4,561

 

0.1

%

 

 

 

 

 

 

 

 

 

 

Total

 

$

 

0.0

%

$

 

0.0

%

 

INVESTMENT IN JOINT VENTURE (Tables)

 

 

Rollforward of the Company’s ownership interest in the joint venture for the year ended March 31, 2014:

 

Balance of ownership interest in joint venture at September 16, 2013

 

$

 

Aggregate 2014 equity loss — share of joint venture losses

 

(313,184

)

2014 equity loss — share of joint venture losses not recognized due to basis limitation

 

313,184

 

Balance of ownership interest in joint venture at March 31, 2014

 

$

 

 

 

 

 

Cumulative unrecognized loss on ownership interest in joint venture at March 31, 2014

 

$

(313,184

)

 

 

Selected financial results for Grace Rich LTD from inception through March 31, 2014 are as follows:

 

Revenues

 

$

 

Expenses

 

1,043,945

 

Net Income (Loss)

 

$

(1,043,945

)

 

 

 

 

Total Assets

 

$

68,297

 

 

 

 

 

Total Liabilities

 

$

1,112,242

 

Total Partners Capital

 

(1,043,945

)

Total Liabilities and Partner Capital

 

$

68,297

 

 

ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)
12 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Antidilutive securities excluded from the calculation of diluted net loss per share
 
 
Cash equivalents
$ 0 
$ 0 
Common stock options and warrants excluded from the calculation of diluted net loss per share (in shares)
9,909,295 
9,609,295 
Other Receivables
 
 
Other receivables
89,192 
 
Inventories
 
 
Raw materials and supplies
35,543 
64,255 
Work in process
25,611 
 
Finished goods
91,663 
474,693 
Inventory, net
152,817 
538,948 
Inventory reserves
100,557 
 
Property, Plant and Equipment
 
 
Total depreciation expense
700,690 
490,136 
Loss on disposal of equipment
129,308 
 
Reserve for loss on impairment of fixed assets acquired from Apollo Diamond in 2012
381,798 
 
Operations in Hudson, Massachusetts
 
 
Property, Plant and Equipment
 
 
Loss on disposal of equipment
$ 129,308 
 
Machinery and equipment |
Minimum
 
 
Property, Plant and Equipment
 
 
Estimated useful lives
3 years 
 
Machinery and equipment |
Maximum
 
 
Property, Plant and Equipment
 
 
Estimated useful lives
15 years 
 
Furniture and fixtures |
Minimum
 
 
Property, Plant and Equipment
 
 
Estimated useful lives
3 years 
 
Furniture and fixtures |
Maximum
 
 
Property, Plant and Equipment
 
 
Estimated useful lives
10 years 
 
Engineering equipment |
Minimum
 
 
Property, Plant and Equipment
 
 
Estimated useful lives
5 years 
 
Engineering equipment |
Maximum
 
 
Property, Plant and Equipment
 
 
Estimated useful lives
12 years 
 
Leasehold improvements |
Minimum
 
 
Property, Plant and Equipment
 
 
Estimated useful lives
3 years 
 
Leasehold improvements |
Maximum
 
 
Property, Plant and Equipment
 
 
Estimated useful lives
7 years 
 
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) (USD $)
12 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Intangible Assets
 
 
Impairment charges
$ 0 
$ 0 
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3) (USD $)
12 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Income taxes
 
 
Significant uncertain income tax positions liability
$ 0 
$ 0 
Revenues |
Customer concentration
 
 
Concentration of credit risk
 
 
Number of customers
27 
 
Revenues |
Customer concentration |
First customer
 
 
Concentration of credit risk
 
 
Concentration risk percentage
58.00% 
84.00% 
Revenues |
Customer concentration |
Second customer
 
 
Concentration of credit risk
 
 
Concentration risk percentage
 
11.00% 
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 4) (ADGC, USD $)
Mar. 31, 2014
Jun. 5, 2012
Fair Value Measurement
 
 
Fair value of subscription rights
$ 770,000 
$ 790,000 
Nonrecurring basis |
Level 3
 
 
Fair Value Measurement
 
 
Fair value of subscription rights
 
$ 770,000 
ASSET PURCHASES (Details) (USD $)
0 Months Ended 12 Months Ended
Jun. 5, 2012
Mar. 31, 2013
Mar. 31, 2014
ADGC Asset Purchase
 
 
 
Asset Purchases
 
 
 
Cash portion of purchase price
$ 100,000 
 
 
Number of shares of common stock issued as consideration for acquisition
1,000,000 
1,000,000 
 
Price per share of common stock issuable as subscription rights (in dollars per share)
$ 0.01 
$ 0.01 
 
Fair value of subscription rights
790,000 
 
770,000 
Fair value of subscription rights (in dollars per right)
$ 0.79 
 
 
Purchase price allocation of the assets
 
 
 
Inventory
269,000 
 
 
In-process research and development
601,000 
 
 
Total
$ 870,000 
 
 
ADI and ADGC
 
 
 
Asset Purchases
 
 
 
Number of shares of common stock issued as consideration for acquisition
 
16,766,773 
 
INTANGIBLE ASSETS (Details) (USD $)
12 Months Ended
Mar. 31, 2014
Mar. 31, 2013
INTANGIBLE ASSETS
 
 
Gross intangible assets
$ 10,385,498 
$ 10,385,498 
Accumulated amortization
1,144,858 
369,847 
Net intangible assets
9,240,640 
10,015,651 
Amortization expense
775,011 
369,847 
In-process research and development
 
 
INTANGIBLE ASSETS
 
 
Acquired finite lived intangible assets
2,250,435 
2,851,435 
Patent
 
 
INTANGIBLE ASSETS
 
 
Acquired finite lived intangible assets
8,135,063 
7,534,063 
Patent |
ADGC Asset Purchase
 
 
INTANGIBLE ASSETS
 
 
Acquired finite lived intangible assets
$ 601,000 
 
Patent |
Minimum
 
 
INTANGIBLE ASSETS
 
 
Amortization period
6 years 9 months 
 
Patent |
Maximum
 
 
INTANGIBLE ASSETS
 
 
Amortization period
19 years 5 months 16 days 
 
INTANGIBLE ASSETS (Details 2) (USD $)
Mar. 31, 2014
Estimated annual amortization expense of intangible assets
 
2015
$ 775,011 
2016
775,011 
2017
775,011 
2018
775,011 
2019
775,011 
Thereafter
$ 3,115,150 
NOTES PAYABLE (Details) (USD $)
0 Months Ended 12 Months Ended 0 Months Ended
Jun. 20, 2014
Line of Credit
Mar. 31, 2014
Line of Credit
Oct. 11, 2013
Line of Credit
Jun. 21, 2013
Line of Credit
Mar. 31, 2014
Line of Credit
Maximum
Oct. 11, 2013
Amended Loan Agreement
Oct. 11, 2013
Additional Loan
Notes payable
 
 
 
 
 
 
 
Maximum borrowing capacity
 
 
 
$ 1,000,000 
 
 
 
Loan draw
 
 
 
 
 
 
280,750 
Annual interest rate (as a percent)
 
18.00% 
 
 
 
18.00% 
 
Accommodation fees (as a percent)
 
 
 
 
10.00% 
 
 
Periodic collateral monitoring fee for the first six months
 
2,000 
 
 
 
 
 
Periodic collateral monitoring fee for the last six months
 
1,000 
 
 
 
 
 
Additional borrowing capacity
 
 
 
 
 
500,000 
 
Applicable fees
 
 
 
 
 
 
30,750 
Interest reserve established
 
 
90,000 
 
 
 
133,500 
Accommodation fees
 
 
 
 
 
25,000 
 
Closing fees
 
 
 
 
 
3,250 
 
Financing costs capitalized
 
 
150,750 
 
 
 
 
Amortization expense related to capitalized financing costs
 
90,917 
 
 
 
 
 
Outstanding balance
 
1,412,060 
 
 
 
 
 
Amount of principal borrowings in total outstanding due
 
1,160,000 
 
 
 
 
 
Amount of interest paid with loan advances in total outstanding due
 
121,310 
 
 
 
 
 
Amount of commitment and other loan fees in total outstanding due
 
$ 130,750 
 
 
 
 
 
Percentage increase in interest rate on the note in default status
3.00% 
 
 
 
 
 
 
Notice period to increase the interest rate of loan in default status
30 days 
 
 
 
 
 
 
CAPITAL STOCK (Details) (USD $)
12 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended
Mar. 31, 2014
item
Mar. 31, 2013
Mar. 31, 2014
Theo Strous
Mar. 31, 2014
Laurence Zipkin
Mar. 31, 2014
Warrants with exercise prices of $0.37 per share
Mar. 31, 2014
Warrants with exercise prices of $.70 per share
Mar. 31, 2014
Warrants with exercise prices of $1.60 per share that expire in 2015
Mar. 31, 2014
Warrants with exercise prices of $1.60 per share that expire in 2018
Mar. 31, 2013
Warrants with exercise prices of $1.60 per share that expire in 2018
Mar. 31, 2013
ADI and ADGC
Jul. 26, 2013
ADI and ADGC
Jun. 5, 2012
ADGC Asset Purchase
Mar. 31, 2013
ADGC Asset Purchase
CAPITAL STOCK
 
 
 
 
 
 
 
 
 
 
 
 
 
Common shares, authorized
75,000,000 
75,000,000 
 
 
 
 
 
 
 
 
 
 
 
Common stock, par value (in dollars per share)
$ 0.001 
$ 0.001 
 
 
 
 
 
 
 
 
$ 0.01 
 
 
Subscription rights issued (in shares)
 
 
 
 
 
 
 
 
 
16,766,773 
 
1,000,000 
1,000,000 
Exercise price per share (in dollars per share)
 
 
 
 
 
 
 
 
 
 
 
$ 0.01 
$ 0.01 
Number of units issued (in shares)
 
4,891,250 
 
 
 
 
 
 
 
 
 
 
 
Number of shares of common stock in each unit issued
 
 
 
 
 
 
 
 
 
 
 
 
Number of warrants in each unit issued
 
 
 
 
 
 
 
 
 
 
 
 
Strike price (in dollars per share)
 
$ 1.60 
 
 
 
 
 
 
 
 
 
 
 
Issue price per unit (in dollars per share)
 
$ 0.80 
 
 
 
 
 
 
 
 
 
 
 
Total net cash proceeds from sale of units
 
$ 3,913,000 
 
 
 
 
 
 
 
 
 
 
 
Common stock issued in exchange for services (in shares)
527,500 
46,250 
 
 
 
 
 
 
 
 
 
 
 
Shares issued upon exercise of certain outstanding warrants
 
19,469 
 
 
 
 
 
 
 
 
 
 
 
Common stock issued for indemnification of legal settlement (in shares)
1,000,000 
 
 
 
 
 
 
 
 
 
 
 
 
Number of board members to whom common stock is issued for indemnification of legal settlement
 
 
 
 
 
 
 
 
 
 
 
 
Number of firms to whom common stock is issued as partial compensation in connection with capital raising activities
 
 
 
 
 
 
 
 
 
 
 
 
Common stock issued in exchange for past legal services (in shares)
1,000,000 
 
 
 
 
 
 
 
 
 
 
 
 
Common stock issued in exchange for past legal services
$ 164,000 
 
 
 
 
 
 
 
 
 
 
 
 
Common Stock issued for participation on a Special Litigation Committee (in shares)
 
 
375,000 
100,000 
 
 
 
 
 
 
 
 
 
Common stock, outstanding (in shares)
50,739,312 
47,736,812 
 
 
 
 
 
 
 
 
 
 
 
Shares held in treasury
1,000,000 
1,000,000 
 
 
 
 
 
 
 
 
 
 
 
Warrants issued in exchange for consulting services (in shares)
 
 
 
 
 
 
 
50,000 
200,000 
 
 
 
 
Fair value (in dollars per share)
$ 0.52 
 
 
 
$ 0.28 
$ 0.52 
 
$ 0.28 
$ 0.57 
 
 
 
 
Common stock, issued (in shares)
50,739,312 
47,736,812 
 
 
 
 
 
 
 
 
 
 
 
Warrants outstanding
5,566,795 
 
 
 
50,000 
425,545 
4,891,250 
 
200,000 
 
 
 
 
Exercise price (in dollars per share)
 
 
 
 
$ 0.37 
$ 0.70 
$ 1.60 
$ 0.37 
$ 1.60 
 
 
 
 
SHARE-BASED COMPENSATION (Details) (USD $)
12 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended
Mar. 31, 2013
Mar. 31, 2014
Mar. 31, 2014
Stock options
item
Mar. 31, 2013
Stock options
May 7, 2012
Stock options
Oct. 2, 2013
Board of Directors
Stock options
Mar. 31, 2014
Board of Directors
Stock options
Mar. 25, 2013
Edward S. Adams
Oct. 2, 2013
Edward S. Adams
Stock options
Oct. 2, 2013
Robert Linares
Stock options
Oct. 2, 2013
Theodorus Strous
Stock options
Sep. 25, 2013
Non-executive employee
item
Mar. 31, 2014
Non-executive employee
Mar. 25, 2013
Michael R. Monahan
Share-based compensation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Number of equity-based compensation plans
 
 
 
 
 
 
 
 
 
 
 
 
 
Number of shares of common stock authorized under the 2012 Share Incentive Plan
 
 
 
 
5,000,000 
 
 
 
 
 
 
 
 
 
Remaining shares available for issuance under the plan
 
 
 
 
 
 
 
 
68,750 
68,750 
68,750 
 
 
 
Number of options to each director for each board meeting held
 
 
 
 
 
6,250 
 
 
 
 
 
 
 
 
Assumptions used to calculate fair value of options
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average calculated value of options granted (in dollars per share)
 
 
 
 
 
$ 0.26 
 
 
 
 
 
$ 0.21 
 
 
Expected dividend yield (as a percent)
 
 
 
 
 
 
0.00% 
 
 
 
 
 
0.00% 
 
Risk-free interest rate (as a percent)
 
 
 
 
 
 
0.66% 
 
 
 
 
 
0.66% 
 
Expected life
 
 
 
 
 
 
3 years 
 
 
 
 
 
3 years 
 
Expected volatility (as a percent)
 
 
 
 
 
 
102.30% 
 
 
 
 
 
102.30% 
 
Options
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Options outstanding at the beginning of the period (in shares)
 
 
4,092,500 
 
 
 
 
 
 
 
 
 
 
 
Granted (in shares)
 
 
706,250 
11,417,500 
 
206,250 
 
 
 
 
 
500,000 
 
 
Expired/Cancelled (in shares)
 
 
(456,250)
(7,325,000)
 
 
 
 
 
 
 
 
 
 
Options outstanding at the end of the period (in shares)
 
 
4,342,500 
4,092,500 
 
 
 
 
 
 
 
 
 
 
Options exercisable at the end of the period (in shares)
 
 
1,927,708 
 
 
 
 
 
 
 
 
 
 
 
Weighted Average Exercise Price
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Options outstanding at the beginning of the period (in dollars per share)
 
 
$ 0.87 
 
 
 
 
 
 
 
 
 
 
 
Granted (in dollars per share)
 
 
$ 0.36 
$ 0.85 
 
 
 
 
 
 
 
$ 0.33 
 
 
Expired/cancelled (in dollars per share)
 
 
$ 0.73 
$ 0.84 
 
 
 
 
 
 
 
 
 
 
Options outstanding at the end of the period (in dollars per share)
 
 
$ 0.77 
$ 0.87 
 
$ 0.42 
 
 
 
 
 
 
 
 
Options exercisable at the end of the period (in dollars per share)
 
 
$ 0.77 
 
 
 
 
 
 
 
 
 
 
 
Weighted-Average Remaining Contractual Term
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Options outstanding at the beginning of the period
 
 
1 year 9 months 
2 years 3 months 14 days 
 
 
 
 
 
 
 
 
 
 
Options outstanding at the end of the period
 
 
1 year 9 months 
2 years 3 months 14 days 
 
 
 
 
 
 
 
 
 
 
Exercisable at the end of the period
 
 
1 year 7 months 17 days 
 
 
 
 
 
 
 
 
 
 
 
Intrinsic value of options outstanding and of options exercisable
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intrinsic value of options outstanding
 
 
$ 0 
$ 299,900 
 
 
 
 
 
 
 
 
 
 
Intrinsic value of options exercisable
 
 
299,900 
 
 
 
 
 
 
 
 
 
 
Shares
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-vested at the beginning of the period (in shares)
 
 
2,466,167 
 
 
 
 
 
 
 
 
 
 
 
Granted (in shares)
 
 
706,250 
11,417,500 
 
 
 
 
 
 
 
 
 
 
Vested (in shares)
 
 
(575,625)
(3,626,333)
 
 
 
 
 
 
 
 
 
 
Expired/cancelled: non-vested (in shares)
 
 
(182,000)
(5,325,000)
 
 
 
 
 
 
 
 
 
 
Non-vested at the end of the period (in shares)
 
 
2,414,792 
2,466,167 
 
 
 
 
 
 
 
 
 
 
Weighted Average Grant-Date Fair Value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-vested at the beginning of the period (in dollars per share)
 
 
$ 0.65 
 
 
 
 
 
 
 
 
 
 
 
Granted (in dollars per share)
 
 
$ 0.22 
$ 0.59 
 
 
 
 
 
 
 
 
 
 
Vested (in dollars per share)
 
 
$ 0.45 
$ 0.55 
 
 
 
 
 
 
 
 
 
 
Expired/cancelled: non-vested (in dollars per share)
 
 
$ 0.38 
$ 0.59 
 
 
 
 
 
 
 
 
 
 
Non-vested at the end of the period (in dollars per share)
 
 
$ 0.49 
$ 0.65 
 
 
 
 
 
 
 
 
 
 
Common shares, authorized
75,000,000 
75,000,000 
 
 
 
 
 
500,000 
 
 
 
 
 
500,000 
Market value per share (in dollars per share)
$ 0.83 
 
 
 
 
 
 
 
 
 
 
 
 
 
Professional and consulting fees related to authorization for indemnity
830,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
Number of employees to whom options to purchase shares of the company's stock are given
 
 
 
 
 
 
 
 
 
 
 
 
 
Options vested immediately on the date of grant (in shares)
 
 
 
 
 
 
 
 
 
 
 
 
 
Total compensation costs
 
 
193,150 
1,996,426 
 
 
54,429 
 
 
 
 
 
5,312 
 
Deferred tax asset recorded, relating to recognized compensation cost
 
 
 
 
 
 
 
 
 
 
 
 
Unrecognized compensation expense
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Unrecognized compensation expense related to nonvested awards
 
 
1,120,222 
 
 
 
 
 
 
 
 
 
 
 
Weighted average period to recognize unrecognized compensation expense related to nonvested awards
 
 
1 year 10 months 6 days 
 
 
 
 
 
 
 
 
 
 
 
Fair value of shares vested
 
 
$ 258,512 
$ 1,873,609 
 
 
 
 
 
 
 
 
 
 
SHARE-BASED COMPENSATION (Details 2) (USD $)
12 Months Ended
Mar. 31, 2014
Options Outstanding
 
Number Outstanding
4,342,500 
Weighted Average Remaining Contractual Life
1 year 9 months 
Weighted Average Exercise Price (in dollars per share)
$ 0.77 
Options Exercisable
 
Number of Shares
1,927,708 
Weighted Average Exercise Price (in dollars per share)
$ 0.77 
$0.83 - $1.02
 
Share-based compensation
 
Range of Exercise Price, low end of range (in dollars per share)
$ 0.83 
Range of Exercise Price, high end of range (in dollars per share)
$ 1.02 
Options Outstanding
 
Number Outstanding
2,343,750 
Weighted Average Remaining Contractual Life
1 year 10 months 17 days 
Weighted Average Exercise Price (in dollars per share)
$ 0.91 
Options Exercisable
 
Number of Shares
885,333 
Weighted Average Exercise Price (in dollars per share)
$ 0.92 
$0.70 - $0.80
 
Share-based compensation
 
Range of Exercise Price, low end of range (in dollars per share)
$ 0.70 
Range of Exercise Price, high end of range (in dollars per share)
$ 0.80 
Options Outstanding
 
Number Outstanding
1,342,500 
Weighted Average Remaining Contractual Life
1 year 2 months 1 day 
Weighted Average Exercise Price (in dollars per share)
$ 0.72 
Options Exercisable
 
Number of Shares
818,500 
Weighted Average Exercise Price (in dollars per share)
$ 0.71 
$0.33 - $0.42
 
Share-based compensation
 
Range of Exercise Price, low end of range (in dollars per share)
$ 0.33 
Range of Exercise Price, high end of range (in dollars per share)
$ 0.42 
Options Outstanding
 
Number Outstanding
656,250 
Weighted Average Remaining Contractual Life
2 years 5 months 26 days 
Weighted Average Exercise Price (in dollars per share)
$ 0.36 
Options Exercisable
 
Number of Shares
223,875 
Weighted Average Exercise Price (in dollars per share)
$ 0.41 
OTHER INCOME AND EXPENSE (Details) (USD $)
12 Months Ended
Mar. 31, 2014
Mar. 31, 2013
OTHER INCOME AND EXPENSE
 
 
Interest expense related to its outstanding note payable
$ 161,439 
 
Forgiveness of interest expense recognized in other income
 
$ 12,522 
OPERATING LEASES (Details) (USD $)
12 Months Ended
Mar. 31, 2014
item
Mar. 31, 2013
OPERATING LEASES
 
 
Number of automobiles leased with lease expirations in fiscal 2015
 
Lease expense
$ 421,038 
$ 426,023 
Deferred rent payable
84,144 
50,195 
Minimum future rental payments
 
 
2015
383,134 
 
2016
347,851 
 
2017
361,660 
 
2018
224,410 
 
2019
224,410 
 
2020 and thereafter
$ 224,411 
 
RELATED PARTIES (Details) (USD $)
12 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 0 Months Ended
Mar. 31, 2013
Mar. 31, 2014
Mar. 31, 2014
Adams Monahan, LLP
Mar. 31, 2013
Adams Monahan, LLP
Mar. 31, 2014
Michael R. Monahan
Mar. 25, 2013
Michael R. Monahan
Claims pertaining to Asset Purchase Agreement
May 14, 2013
Theodorus Strous
Mar. 31, 2014
Theodorus Strous
Mar. 6, 2013
Theo Strous and Michael R. Monahan
item
Mar. 31, 2014
Theo Strous and Michael R. Monahan
Mar. 31, 2013
Theo Strous and Michael R. Monahan
Jul. 2, 2013
Messrs. Adams and Monahan
May 21, 2013
Messrs. Adams and Monahan
Jan. 6, 2014
Mr. Theo Strous and Mr. Laurence Zipkin
Mar. 31, 2014
Mr. Theo Strous and Mr. Laurence Zipkin
Mar. 25, 2014
Mr. Laurence Zipkin
Mar. 25, 2013
Edward S. Adams
Claims pertaining to Asset Purchase Agreement
Related parties
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expenses for professional and consulting services provided by related party
 
 
$ 19,658 
$ 106,229 
$ 11,000 
 
$ 25,000 
$ 4,000 
 
$ 45,000 
$ 15,000 
 
 
 
 
 
 
Number of board members retained for consulting services
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Shares issued to the related party to indemnify for settlement of litigation
 
 
 
 
 
500,000 
 
 
 
 
 
 
 
 
 
 
500,000 
Payment to the related party to indemnify for settlement of litigation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
90,000 
Expense related to indemnification
946,555 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-cash indemnification attributable to common stock to be issued
830,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Shares issued previously allocated for indemnification of directors
 
 
 
 
 
 
 
 
 
 
 
 
1,000,000 
 
 
 
 
Remaining indemnification liability
 
 
 
 
 
 
 
 
 
 
 
117,306 
 
 
 
 
 
Remaining indemnification liability per month
 
 
 
 
 
 
 
 
 
 
 
7,500 
 
 
 
 
 
One-time payment to be received by the each member of the Special Litigation Committee upon completion of the investigation
 
 
 
 
 
 
 
 
 
 
 
 
 
50,000 
 
50,000 
 
Shares of common stock to be received by the each member of the Special Litigation Committee upon completion of the investigation
 
 
 
 
 
 
 
 
 
 
 
 
 
100,000 
 
100,000 
 
Shares of common stock to be received by the each member of the Special Litigation Committee upon completion of the investigation in lieu of cash and share amount
 
 
 
 
 
 
 
 
 
 
 
 
 
375,000 
 
 
 
Consulting expenses
 
 
 
 
 
 
 
93,750 
 
 
 
 
 
 
168,750 
 
 
Due to related party
 
$ 215,306 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INCOME TAXES (Details) (USD $)
12 Months Ended
Mar. 31, 2014
Mar. 31, 2013
INCOME TAXES
 
 
Current tax expense (benefit)
$ 0 
$ 0 
Deferred tax expense (benefit)
Deferred tax asset (liability)
 
 
Accrued expenses
235,998 
187,640 
Property and equipment
(150,810)
(112,563)
Impairment of fixed assets
142,767 
 
Capitalized startup/acquisition costs
499,288 
633,713 
Federal and state net operating loss carry-forward
3,857,269 
2,122,402 
Trade name
 
92,572 
Intangible assets
14,537 
(55,685)
Nonqualified options and warrants granted for services
 
59,029 
Valuation allowance
(4,599,049)
(2,927,108)
Amount
 
 
Tax at statutory federal income tax rate
(1,683,324)
(2,476,000)
Increase (decrease) resulting from:
 
 
Change in valuation allowance
1,671,941 
1,846,204 
Incentive stock options
 
625,235 
Other, Net
11,383 
4,561 
%
 
 
Tax at statutory federal income tax rate (as a percent)
(34.00%)
(34.00%)
Increase (decrease) resulting from:
 
 
State income tax expense (as a percent)
0.00% 
0.00% 
Change in valuation allowance (as a percent)
33.80% 
25.30% 
Incentive stock options (as a percent)
0.00% 
8.60% 
Other, Net (as a percent)
0.20% 
0.10% 
Total (as a percent)
0.00% 
0.00% 
Federal and state net operating loss carry-forwards
$ 10,266,576 
$ 5,646,000 
INVESTMENT IN JOINT VENTURE (Details) (USD $)
0 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 16, 2013
item
Mar. 31, 2014
Jun. 30, 2014
Mar. 31, 2014
Investment in joint venture
 
 
 
 
Licensing fees
 
 
 
$ 625,000 
Grace Rich Agreements
 
 
 
 
Investment in joint venture
 
 
 
 
Ownership percentage in joint venture
30.00% 
 
 
 
Grace Rich Agreements |
Minimum
 
 
 
 
Investment in joint venture
 
 
 
 
Ownership percentage in joint venture
30.00% 
 
 
 
Grace Rich Limited
 
 
 
 
Investment in joint venture
 
 
 
 
Minimum number of Company designed diamond growing machines to be deployed in joint venture
100 
 
 
 
Ownership percentage in joint venture
30.00% 
 
 
 
Licensing fees
 
 
250,000 
 
Development fees
 
 
750,000 
 
Licensing fees per machine per month
 
 
 
250 
Initial investment value
 
 
 
Rollforward of the Company's ownership interest in the joint venture
 
 
 
 
Aggregate 2014 equity loss - share of joint venture losses
 
 
 
(313,184)
2014 equity loss - share of joint venture losses not recognized due to basis limitation
 
 
 
313,184 
Balance of ownership interest in joint venture at March 31, 2014
 
 
 
Cumulative unrecognized loss on ownership interest in joint venture at March 31, 2014
 
(313,184)
 
(313,184)
Selected financial results
 
 
 
 
Revenues
 
 
 
625,000 
Expenses
 
1,043,945 
 
151,359 
Net Income (Loss)
 
(1,043,945)
 
 
Total Assets
 
68,297 
 
68,297 
Total Liabilities
 
1,112,242 
 
1,112,242 
Total Partners Capital
 
(1,043,945)
 
(1,043,945)
Total Liabilities and Partner Capital
 
68,297 
 
68,297 
Revenues from joint venture
 
 
 
625,000 
Joint venture related expenses
 
1,043,945 
 
151,359 
Grace Rich Limited |
Minimum
 
 
 
 
Investment in joint venture
 
 
 
 
Licensing fees per month
 
 
 
$ 25,000 
Grace Rich Limited |
SAAMABA, LLC
 
 
 
 
Investment in joint venture
 
 
 
 
Ownership percentage in joint venture
60.00% 
 
 
 
Grace Rich Limited |
S21 Holdings
 
 
 
 
Investment in joint venture
 
 
 
 
Ownership percentage in joint venture
10.00% 
 
 
 
LITIGATION (Details) (USD $)
In Millions, except Per Share data, unless otherwise specified
0 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Jul. 26, 2013
ADI
Jul. 26, 2013
ADGC
Jul. 26, 2013
ADI and ADGC
Litigation
 
 
 
 
 
Maximum number of shares that can be acquired
 
 
16 
 
Common stock, par value (in dollars per share)
$ 0.001 
$ 0.001 
 
 
$ 0.01 
SUBSEQUENT EVENTS (Details) (USD $)
12 Months Ended 0 Months Ended 1 Months Ended 0 Months Ended 3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Jun. 20, 2014
Loan facilities with Platinum
Aug. 8, 2014
Subsequent events
Accredited investors
Jul. 15, 2014
Subsequent events
Accredited investors
Aug. 8, 2014
Subsequent events
Accredited investors
Maximum
Jun. 20, 2014
Subsequent events
Loan facilities with Platinum
May 27, 2014
Subsequent events
Messrs. Korn
May 27, 2014
Subsequent events
McGuire
Jun. 16, 2014
Subsequent events
Mr. Likly
Jun. 20, 2014
Subsequent events
Mr. Michael Laub
Jun. 23, 2014
Subsequent events
Settlement agreement
Adams Group and the Save Scio Group
item
Jun. 23, 2014
Subsequent events
Settlement agreement
The Save Scio Group
Jun. 23, 2014
Subsequent events
Settlement agreement
Messrs. Korn
Jun. 23, 2014
Subsequent events
Settlement agreement
McGuire
Jun. 23, 2014
Subsequent events
Settlement agreement
Mr. Likly
Jun. 23, 2014
Subsequent events
Settlement agreement
Messrs. Adams and Monahan
Apr. 15, 2014
Subsequent events
Rights Agreement
Apr. 12, 2014
Subsequent events
Mr. Joseph Cunningham
Jun. 30, 2014
Subsequent events
Mr. Joseph Cunningham
Subsequent events
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consulting expenses
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
$ 4,000 
 
Common stock issued in exchange for consulting services (in shares)
527,500 
46,250 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
60,000 
Common stock issued in exchange for consulting services per month (in shares)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
20,000 
 
Average value per share (in dollars per share)
 
$ 0.83 
 
 
$ 0.30 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
$ 0.44 
Expenses for professional and consulting services provided by related party
319,200 
37,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
26,200 
Number of common stock purchase right declared as dividend for each share of common stock
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Par value of each share of common stock for which common stock purchase right declared as dividend (in dollars per share)
$ 0.001 
$ 0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
$ 0.001 
 
 
Shares of common stock that can be purchased from each right
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Purchase Price (in dollars per share)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
$ 1.20 
 
 
Minimum percentage of outstanding common stock to be acquired to be considered an "Acquiring Person" following issuance of rights agreement
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.17 
 
 
Minimum percentage of outstanding common stock to be acquired not to be considered an "Acquiring Person" before issuance of rights agreement
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.17 
 
 
Threshold percentage ownership of common stock required for rights to be exercisable
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17.00% 
 
 
Shares of restricted stock issued upon appointment to the Board
 
 
 
 
 
 
 
250,000 
250,000 
4,000,000 
50,000 
 
 
 
 
 
 
 
 
 
Amount of loan facility into default status
 
 
 
 
 
 
1,500,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
Percentage increase in interest rate on the note in default status
 
 
3.00% 
 
 
 
3.00% 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notice period to increase the interest rate of loan in default status
 
 
30 days 
 
 
 
30 days 
 
 
 
 
 
 
 
 
 
 
 
 
 
Number of directors in expanded size of board
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Period for which counterparty to the agreement must vote their shares of Common Stock for the other's nominees
 
 
 
 
 
 
 
 
 
 
 
3 years 
 
 
 
 
 
 
 
 
Shares of common stock to be transferred to counterparty
 
 
 
 
 
 
 
 
 
 
 
 
1,000,000 
 
 
 
 
 
 
 
Past accrued liabilities and expenses due to the settling parties reversed
573,126 
730,698 
 
 
 
 
 
 
 
 
 
(340,000)
 
 
 
 
 
 
 
 
Shares forfeited
 
 
 
 
 
 
 
 
 
 
 
 
 
250,000 
250,000 
4,000,000 
1,000,000 
 
 
 
Number of shares of common stock issued
 
 
 
750,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Number of shares of common stock approved for issuance
 
 
 
 
 
2,000,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stock issued
 
3,873,177 
 
225,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Potential amount raised from offering
 
 
 
 
 
$ 600,000